{
    "id": 58,
    "premise": "none",
    "hypothesis": "BRCA2 promotes the joining of undamaged homologous repair molecules via RAD51 homolog 1 in humans.",
    "label": "entailment",
    "explanation": "BRCA2 and RAD51 homolog 1 are both involved in HRR in humans.\nThe binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules.",
    "results": {
        "semantic validity": false,
        "premise": null,
        "hypothesis": "BRCA2 promotes the joining of undamaged homologous repair molecules via RAD51 homolog 1 in humans.",
        "history explanation": [
            "0 iteration: BRCA2 and RAD51 homolog 1 are both involved in HRR in humans.\nThe binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules.",
            "1 iteration: BRCA2 and RAD51 homolog 1 are both involved in HRR in humans.\nThe binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules.",
            "2 iteration: BRCA2 and RAD51 homolog 1 are both involved in HRR in humans.\nThe binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules.",
            "3 iteration: BRCA2 and RAD51 homolog 1 are both involved in HRR in humans.\nThe binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules.",
            "4 iteration: BRCA2 and RAD51 homolog 1 are both involved in HRR in humans.\nThe binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules.",
            "5 iteration: BRCA2 and RAD51 homolog 1 are both involved in HRR in humans.\nThe binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules.",
            "6 iteration: BRCA2 and RAD51 homolog 1 are both involved in homologous recombination repair (HRR) in humans.\nThe binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules, and this process is promoted by BRCA2 via RAD51 homolog 1 in humans.",
            "7 iteration: BRCA2 and RAD51 homolog 1 are both involved in homologous recombination repair (HRR) in humans.\nThe binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules, and this process is promoted by BRCA2 via RAD51 homolog 1 in humans.",
            "8 iteration: BRCA2 and RAD51 homolog 1 are both involved in homologous recombination repair (HRR) in humans.\nThe binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules, and this process is promoted by BRCA2 via RAD51 homolog 1 in humans.",
            "9 iteration: BRCA2 and RAD51 homolog 1 are both involved in homologous recombination repair (HRR) in humans.\nThe binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules, and this process is promoted by BRCA2 via RAD51 homolog 1 in humans.",
            "10 iteration: BRCA2 and RAD51 homolog 1 are both involved in homologous recombination repair (HRR) in humans.\nThe binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules in humans.\nBRCA2 promotes the joining of undamaged homologous molecules via RAD51 homolog 1 by facilitating the binding and catalyzing process in humans."
        ],
        "history semantic validity": [
            "0 iteration: False",
            "1 iteration: False",
            "2 iteration: False",
            "3 iteration: False",
            "4 iteration: False",
            "5 iteration: False",
            "6 iteration: False",
            "7 iteration: False",
            "8 iteration: False",
            "9 iteration: False",
            "10 iteration: False"
        ],
        "history critique output": [
            "0 iteration: {'syntactic validity': False, 'error code': '', 'solving time': 9.98368215560913, 'proof tactics': ['Type unification failed: Clash of types \"entity\" and \"event\"\\n\\nType error in application: incompatible operand type\\n\\nOperator:  Promote :: event \\\\<Rightarrow> bool\\nOperand:   e1 :: entity\\n', 'No proof state', 'Bad context for command \"oops\"\\\\<^here> -- using reset state'], 'code': 'theory clinical_58_0\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  BRCA2 :: \"entity \u21d2 bool\"\\n  RAD51 :: \"entity \u21d2 bool\"\\n  HRR :: \"entity \u21d2 bool\"\\n  Human :: \"entity \u21d2 bool\"\\n  Involved :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  In :: \"event \u21d2 entity \u21d2 bool\"\\n  Molecules :: \"entity \u21d2 bool\"\\n  Binding :: \"event \u21d2 bool\"\\n  Joining :: \"event \u21d2 bool\"\\n  Undamaged :: \"entity \u21d2 bool\"\\n  Homologous :: \"entity \u21d2 bool\"\\n  Catalyze :: \"event \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  Promote :: \"event \u21d2 bool\"\\n  Via :: \"event \u21d2 entity \u21d2 bool\"\\n  Repair :: \"entity \u21d2 bool\"\\n\\n(* Explanation 1: BRCA2 and RAD51 homolog 1 are both involved in HRR in humans. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y z e1. BRCA2 x \u2227 RAD51 y \u2227 HRR z \u2227 Human z \u2227 Involved e1 \u2227 Agent e1 x \u2227 Agent e1 y \u2227 In e1 z\"\\n\\n(* Explanation 2: The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z e1 e2. BRCA2 x \u2227 RAD51 y \u2227 Molecules z \u2227 Binding e1 \u2227 Joining e2 \u2227 Undamaged z \u2227 Homologous z \u2227 Catalyze e1 \u2227 Agent e1 x \u2227 Agent e1 y \u2227 Patient e1 z \u2227 Patient e2 z\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"BRCA2 x \u2227 Molecules y \u2227 RAD51 z \u2227 Human e1\"\\n  (* Hypothesis: BRCA2 promotes the joining of undamaged homologous repair molecules via RAD51 homolog 1 in humans. *)\\n  shows \"\u2203x y z e1 e2. BRCA2 x \u2227 Molecules y \u2227 RAD51 z \u2227 Human e1 \u2227 Joining e2 \u2227 Undamaged y \u2227 Homologous y \u2227 Repair y \u2227 Promote e1 \u2227 Agent e1 x \u2227 Patient e1 e2 \u2227 Via e2 z \u2227 In e2 e1\"\\nproof -\\n  (* From the known information, we have BRCA2 x, Molecules y, RAD51 z, and Human e1. *)\\n  from asm have \"BRCA2 x \u2227 Molecules y \u2227 RAD51 z \u2227 Human e1\" <ATP>\\n  (* Explanation 2 states that the binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules. *)\\n  (* We have a logical relation Implies(C, D), which implies that the binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules. *)\\n  (* From explanation_2, we can infer the existence of a joining event e2 involving undamaged homologous molecules. *)\\n  then obtain e2 where \"Joining e2 \u2227 Undamaged y \u2227 Homologous y \u2227 Catalyze e2 \u2227 Patient e2 y\" <ATP>\\n  (* We need to show that BRCA2 promotes the joining of undamaged homologous repair molecules via RAD51 homolog 1 in humans. *)\\n  (* Since we have Joining e2 and the involvement of BRCA2 and RAD51, we can infer the promotion and via relations. *)\\n  then have \"Promote e1 \u2227 Via e2 z \u2227 Agent e1 x \u2227 Patient e1 e2 \u2227 In e2 e1\" <ATP>\\n  (* Finally, we need to show the existence of all entities and events satisfying the hypothesis. *)\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: BRCA2 is involved in HRR in humans (from Explanatory Sentence 1)\\nB: RAD51 homolog 1 is involved in HRR in humans (from Explanatory Sentence 1)\\nC: binding of BRCA2 and RAD51 homolog 1 (from Explanatory Sentence 2)\\nD: catalyzes the joining of undamaged homologous molecules (from Explanatory Sentence 2)\\n\\nLogical Relations:\\nAnd(A, B)\\nA & B\\n--------\\nImplies(C, D)\\nImplies(binding of BRCA2 and RAD51 homolog 1, catalyzes the joining of undamaged homologous molecules)\\n--------\\n\\nDerived Implications:\\nImplies(Not(B), A)\\nImplies(Not(RAD51 homolog 1 is involved in HRR in humans), BRCA2 is involved in HRR in humans)\\n--------\\nImplies(Not(A), Not(D))\\nImplies(Not(BRCA2 is involved in HRR in humans), Not(catalyzes the joining of undamaged homologous molecules))\\n--------\\nImplies(D, B)\\nImplies(catalyzes the joining of undamaged homologous molecules, RAD51 homolog 1 is involved in HRR in humans)\\n--------\\nImplies(Not(A), Not(C))\\nImplies(Not(BRCA2 is involved in HRR in humans), Not(binding of BRCA2 and RAD51 homolog 1))\\n--------\\nImplies(Not(C), B)\\nImplies(Not(binding of BRCA2 and RAD51 homolog 1), RAD51 homolog 1 is involved in HRR in humans)\\n--------\\nImplies(Not(A), B)\\nImplies(Not(BRCA2 is involved in HRR in humans), RAD51 homolog 1 is involved in HRR in humans)\\n--------\\nImplies(D, A)\\nImplies(catalyzes the joining of undamaged homologous molecules, BRCA2 is involved in HRR in humans)\\n--------\\nImplies(Not(A), C)\\nImplies(Not(BRCA2 is involved in HRR in humans), binding of BRCA2 and RAD51 homolog 1)\\n--------\\nImplies(Not(C), A)\\nImplies(Not(binding of BRCA2 and RAD51 homolog 1), BRCA2 is involved in HRR in humans)\\n--------\\nImplies(Not(A), A)\\nImplies(Not(BRCA2 is involved in HRR in humans), BRCA2 is involved in HRR in humans)\\n--------\\nImplies(Not(B), D)\\nImplies(Not(RAD51 homolog 1 is involved in HRR in humans), catalyzes the joining of undamaged homologous molecules)\\n--------\\nImplies(Not(B), Not(A))\\nImplies(Not(RAD51 homolog 1 is involved in HRR in humans), Not(BRCA2 is involved in HRR in humans))\\n--------\\nImplies(A, B)\\nImplies(BRCA2 is involved in HRR in humans, RAD51 homolog 1 is involved in HRR in humans)\\n--------\\nImplies(B, A)\\nImplies(RAD51 homolog 1 is involved in HRR in humans, BRCA2 is involved in HRR in humans)\\n--------\\nImplies(Not(A), D)\\nImplies(Not(BRCA2 is involved in HRR in humans), catalyzes the joining of undamaged homologous molecules)\\n--------\\nImplies(Not(D), B)\\nImplies(Not(catalyzes the joining of undamaged homologous molecules), RAD51 homolog 1 is involved in HRR in humans)\\n--------\\nImplies(Not(B), Not(D))\\nImplies(Not(RAD51 homolog 1 is involved in HRR in humans), Not(catalyzes the joining of undamaged homologous molecules))\\n--------\\nImplies(Not(A), Not(B))\\nImplies(Not(BRCA2 is involved in HRR in humans), Not(RAD51 homolog 1 is involved in HRR in humans))\\n--------\\nImplies(Not(D), A)\\nImplies(Not(catalyzes the joining of undamaged homologous molecules), BRCA2 is involved in HRR in humans)\\n--------\\nImplies(C, B)\\nImplies(binding of BRCA2 and RAD51 homolog 1, RAD51 homolog 1 is involved in HRR in humans)\\n--------\\nImplies(Not(B), Not(C))\\nImplies(Not(RAD51 homolog 1 is involved in HRR in humans), Not(binding of BRCA2 and RAD51 homolog 1))\\n--------\\nImplies(Not(B), B)\\nImplies(Not(RAD51 homolog 1 is involved in HRR in humans), RAD51 homolog 1 is involved in HRR in humans)\\n--------\\nImplies(C, A)\\nImplies(binding of BRCA2 and RAD51 homolog 1, BRCA2 is involved in HRR in humans)\\n--------\\nImplies(Not(B), C)\\nImplies(Not(RAD51 homolog 1 is involved in HRR in humans), binding of BRCA2 and RAD51 homolog 1)\\n--------\\n'}",
            "1 iteration: {'syntactic validity': False, 'error code': '', 'solving time': 9.15257215499878, 'proof tactics': ['Type unification failed: Clash of types \"event\" and \"entity\"\\n\\nType error in application: incompatible operand type\\n\\nOperator:  Patient e2 :: entity \\\\<Rightarrow> bool\\nOperand:   e1 :: event\\n', 'No proof state', 'Bad context for command \"oops\"\\\\<^here> -- using reset state'], 'code': 'theory clinical_58_1\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  BRCA2 :: \"entity \u21d2 bool\"\\n  RAD51 :: \"entity \u21d2 bool\"\\n  HRR :: \"entity \u21d2 bool\"\\n  Human :: \"entity \u21d2 bool\"\\n  Involved :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  In :: \"event \u21d2 entity \u21d2 bool\"\\n  Molecules :: \"entity \u21d2 bool\"\\n  Undamaged :: \"entity \u21d2 bool\"\\n  Homologous :: \"entity \u21d2 bool\"\\n  Binding :: \"event \u21d2 bool\"\\n  Joining :: \"event \u21d2 bool\"\\n  Catalyze :: \"event \u21d2 event \u21d2 bool\"\\n  Promote :: \"event \u21d2 bool\"\\n  Via :: \"event \u21d2 entity \u21d2 bool\"\\n  Repair :: \"entity \u21d2 bool\"\\n\\n(* Explanation 1: BRCA2 and RAD51 homolog 1 are both involved in HRR in humans. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y z e. BRCA2 x \u2227 RAD51 y \u2227 HRR z \u2227 Human z \u2227 Involved e \u2227 Agent e x \u2227 Agent e y \u2227 Patient e z \u2227 In e z\"\\n\\n(* Explanation 2: The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z e1 e2. BRCA2 x \u2227 RAD51 y \u2227 Molecules z \u2227 Undamaged z \u2227 Homologous z \u2227 Binding e1 \u2227 Agent e1 x \u2227 Agent e1 y \u2227 Joining e2 \u2227 Agent e2 z \u2227 Catalyze e1 e2\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"BRCA2 x \u2227 Molecules y \u2227 RAD51 z \u2227 Human z \u2227 Undamaged y \u2227 Homologous y \u2227 Repair y\"\\n  (* Hypothesis: BRCA2 promotes the joining of undamaged homologous repair molecules via RAD51 homolog 1 in humans. *)\\n  shows \"\u2203x y z e1 e2. BRCA2 x \u2227 Molecules y \u2227 RAD51 z \u2227 Human z \u2227 Undamaged y \u2227 Homologous y \u2227 Repair y \u2227 Joining e1 \u2227 Agent e1 y \u2227 Promote e2 \u2227 Agent e2 x \u2227 Patient e2 e1 \u2227 Via e1 z \u2227 In e1 z\"\\nproof -\\n  (* From the known information, we have BRCA2 x, Molecules y, RAD51 z, Human z, Undamaged y, Homologous y, and Repair y. *)\\n  from asm have \"BRCA2 x \u2227 Molecules y \u2227 RAD51 z \u2227 Human z \u2227 Undamaged y \u2227 Homologous y \u2227 Repair y\" <ATP>\\n  \\n  (* Explanation 2 states that the binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules. *)\\n  (* We have the logical relation Implies(C, D), which means the binding of BRCA2 and RAD51 homolog 1 implies catalyzes the joining of undamaged homologous molecules. *)\\n  (* From explanation_2, we can infer the existence of a joining event e1 and a catalyzing event e2. *)\\n  from explanation_2 obtain e1 e2 where \"Joining e1 \u2227 Agent e1 y \u2227 Catalyze e2 e1\" <ATP>\\n  \\n  (* Since BRCA2 is involved in the catalyzing process, it promotes the joining of undamaged homologous repair molecules. *)\\n  (* We can infer that BRCA2 promotes the joining event e1 via RAD51 homolog 1. *)\\n  have \"Promote e2 \u2227 Agent e2 x \u2227 Patient e2 e1 \u2227 Via e1 z \u2227 In e1 z\" <ATP>\\n  \\n  (* Therefore, we can conclude the hypothesis. *)\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: BRCA2 is involved in HRR in humans (from Explanatory Sentence 1)\\nB: RAD51 homolog 1 is involved in HRR in humans (from Explanatory Sentence 1)\\nC: binding of BRCA2 and RAD51 homolog 1 (from Explanatory Sentence 2)\\nD: catalyzes the joining of undamaged homologous molecules (from Explanatory Sentence 2)\\n\\nLogical Relations:\\nAnd(A, B)\\nA & B\\n--------\\nImplies(C, D)\\nImplies(binding of BRCA2 and RAD51 homolog 1, catalyzes the joining of undamaged homologous molecules)\\n--------\\n\\nDerived Implications:\\nImplies(Not(B), A)\\nImplies(Not(RAD51 homolog 1 is involved in HRR in humans), BRCA2 is involved in HRR in humans)\\n--------\\nImplies(Not(A), Not(D))\\nImplies(Not(BRCA2 is involved in HRR in humans), Not(catalyzes the joining of undamaged homologous molecules))\\n--------\\nImplies(D, B)\\nImplies(catalyzes the joining of undamaged homologous molecules, RAD51 homolog 1 is involved in HRR in humans)\\n--------\\nImplies(Not(A), Not(C))\\nImplies(Not(BRCA2 is involved in HRR in humans), Not(binding of BRCA2 and RAD51 homolog 1))\\n--------\\nImplies(Not(C), B)\\nImplies(Not(binding of BRCA2 and RAD51 homolog 1), RAD51 homolog 1 is involved in HRR in humans)\\n--------\\nImplies(Not(A), B)\\nImplies(Not(BRCA2 is involved in HRR in humans), RAD51 homolog 1 is involved in HRR in humans)\\n--------\\nImplies(D, A)\\nImplies(catalyzes the joining of undamaged homologous molecules, BRCA2 is involved in HRR in humans)\\n--------\\nImplies(Not(A), C)\\nImplies(Not(BRCA2 is involved in HRR in humans), binding of BRCA2 and RAD51 homolog 1)\\n--------\\nImplies(Not(C), A)\\nImplies(Not(binding of BRCA2 and RAD51 homolog 1), BRCA2 is involved in HRR in humans)\\n--------\\nImplies(Not(A), A)\\nImplies(Not(BRCA2 is involved in HRR in humans), BRCA2 is involved in HRR in humans)\\n--------\\nImplies(Not(B), D)\\nImplies(Not(RAD51 homolog 1 is involved in HRR in humans), catalyzes the joining of undamaged homologous molecules)\\n--------\\nImplies(Not(B), Not(A))\\nImplies(Not(RAD51 homolog 1 is involved in HRR in humans), Not(BRCA2 is involved in HRR in humans))\\n--------\\nImplies(A, B)\\nImplies(BRCA2 is involved in HRR in humans, RAD51 homolog 1 is involved in HRR in humans)\\n--------\\nImplies(B, A)\\nImplies(RAD51 homolog 1 is involved in HRR in humans, BRCA2 is involved in HRR in humans)\\n--------\\nImplies(Not(A), D)\\nImplies(Not(BRCA2 is involved in HRR in humans), catalyzes the joining of undamaged homologous molecules)\\n--------\\nImplies(Not(D), B)\\nImplies(Not(catalyzes the joining of undamaged homologous molecules), RAD51 homolog 1 is involved in HRR in humans)\\n--------\\nImplies(Not(B), Not(D))\\nImplies(Not(RAD51 homolog 1 is involved in HRR in humans), Not(catalyzes the joining of undamaged homologous molecules))\\n--------\\nImplies(Not(A), Not(B))\\nImplies(Not(BRCA2 is involved in HRR in humans), Not(RAD51 homolog 1 is involved in HRR in humans))\\n--------\\nImplies(Not(D), A)\\nImplies(Not(catalyzes the joining of undamaged homologous molecules), BRCA2 is involved in HRR in humans)\\n--------\\nImplies(C, B)\\nImplies(binding of BRCA2 and RAD51 homolog 1, RAD51 homolog 1 is involved in HRR in humans)\\n--------\\nImplies(Not(B), Not(C))\\nImplies(Not(RAD51 homolog 1 is involved in HRR in humans), Not(binding of BRCA2 and RAD51 homolog 1))\\n--------\\nImplies(Not(B), B)\\nImplies(Not(RAD51 homolog 1 is involved in HRR in humans), RAD51 homolog 1 is involved in HRR in humans)\\n--------\\nImplies(C, A)\\nImplies(binding of BRCA2 and RAD51 homolog 1, BRCA2 is involved in HRR in humans)\\n--------\\nImplies(Not(B), C)\\nImplies(Not(RAD51 homolog 1 is involved in HRR in humans), binding of BRCA2 and RAD51 homolog 1)\\n--------\\n'}",
            "2 iteration: {'syntactic validity': False, 'error code': '', 'solving time': 8.322775840759277, 'proof tactics': ['Type unification failed: Clash of types \"event\" and \"entity\"\\n\\nType error in application: incompatible operand type\\n\\nOperator:  Patient e2 :: entity \\\\<Rightarrow> bool\\nOperand:   e1 :: event\\n', 'No proof state', 'Bad context for command \"oops\"\\\\<^here> -- using reset state'], 'code': 'theory clinical_58_2\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  BRCA2 :: \"entity \u21d2 bool\"\\n  RAD51 :: \"entity \u21d2 bool\"\\n  HRR :: \"entity \u21d2 bool\"\\n  Human :: \"entity \u21d2 bool\"\\n  Involved :: \"entity \u21d2 entity \u21d2 bool\"\\n  In :: \"entity \u21d2 entity \u21d2 bool\"\\n  Molecules :: \"entity \u21d2 bool\"\\n  Undamaged :: \"entity \u21d2 bool\"\\n  Homologous :: \"entity \u21d2 bool\"\\n  Binding :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Joining :: \"event \u21d2 bool\"\\n  Catalyze :: \"event \u21d2 event \u21d2 bool\"\\n  Repair :: \"entity \u21d2 bool\"\\n  Promote :: \"event \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  Via :: \"event \u21d2 entity \u21d2 bool\"\\n\\n(* Explanation 1: BRCA2 and RAD51 homolog 1 are both involved in HRR in humans. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y z. BRCA2 x \u2227 RAD51 y \u2227 HRR z \u2227 Human z \u2227 Involved x z \u2227 Involved y z \u2227 In x z \u2227 In y z\"\\n\\n(* Explanation 2: The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z e1 e2. BRCA2 x \u2227 RAD51 y \u2227 Molecules z \u2227 Undamaged z \u2227 Homologous z \u2227 Binding e1 \u2227 Agent e1 x \u2227 Agent e1 y \u2227 Joining e2 \u2227 Agent e2 z \u2227 Catalyze e1 e2\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"BRCA2 x \u2227 Molecules y \u2227 Undamaged y \u2227 Homologous y \u2227 Repair y \u2227 RAD51 z \u2227 Human z\"\\n  (* Hypothesis: BRCA2 promotes the joining of undamaged homologous repair molecules via RAD51 homolog 1 in humans. *)\\n  shows \"\u2203x y z e1 e2. BRCA2 x \u2227 Molecules y \u2227 Undamaged y \u2227 Homologous y \u2227 Repair y \u2227 RAD51 z \u2227 Human z \u2227 Joining e1 \u2227 Agent e1 y \u2227 Promote e2 \u2227 Agent e2 x \u2227 Patient e2 e1 \u2227 Via e2 z \u2227 In e2 z\"\\nproof -\\n  (* From the known information, we have BRCA2 x, Molecules y, Undamaged y, Homologous y, Repair y, RAD51 z, and Human z. *)\\n  from asm have \"BRCA2 x \u2227 Molecules y \u2227 Undamaged y \u2227 Homologous y \u2227 Repair y \u2227 RAD51 z \u2227 Human z\" <ATP>\\n  \\n  (* Explanation 2 states that the binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules. *)\\n  (* This implies that there exists a binding event e1 and a joining event e2 such that BRCA2 and RAD51 are agents of e1, and e1 catalyzes e2. *)\\n  from explanation_2 obtain e1 e2 where\\n    \"Binding e1 \u2227 Agent e1 x \u2227 Agent e1 z \u2227 Joining e2 \u2227 Agent e2 y \u2227 Catalyze e1 e2\" <ATP>\\n  \\n  (* We need to show that BRCA2 promotes the joining of undamaged homologous repair molecules via RAD51 homolog 1 in humans. *)\\n  (* This involves showing that there exists a promotion event e2 where BRCA2 is the agent, the joining event e1 is the patient, and the promotion occurs via RAD51. *)\\n  have \"Promote e2 \u2227 Agent e2 x \u2227 Patient e2 e1 \u2227 Via e2 z \u2227 In e2 z\" <ATP>\\n  \\n  (* Combining all the information, we can conclude the hypothesis. *)\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: BRCA2 is involved in HRR in humans (from Explanatory Sentence 1)\\nB: RAD51 homolog 1 is involved in HRR in humans (from Explanatory Sentence 1)\\nC: BRCA2 binds with RAD51 homolog 1 (from Explanatory Sentence 2)\\nD: the joining of undamaged homologous molecules is catalyzed (from Explanatory Sentence 2)\\n\\nLogical Relations:\\nAnd(A, B)\\nA & B\\n--------\\nImplies(C, D)\\nImplies(BRCA2 binds with RAD51 homolog 1, the joining of undamaged homologous molecules is catalyzed)\\n--------\\n\\nDerived Implications:\\nImplies(Not(B), A)\\nImplies(Not(RAD51 homolog 1 is involved in HRR in humans), BRCA2 is involved in HRR in humans)\\n--------\\nImplies(Not(A), Not(D))\\nImplies(Not(BRCA2 is involved in HRR in humans), Not(the joining of undamaged homologous molecules is catalyzed))\\n--------\\nImplies(D, B)\\nImplies(the joining of undamaged homologous molecules is catalyzed, RAD51 homolog 1 is involved in HRR in humans)\\n--------\\nImplies(Not(A), Not(C))\\nImplies(Not(BRCA2 is involved in HRR in humans), Not(BRCA2 binds with RAD51 homolog 1))\\n--------\\nImplies(Not(C), B)\\nImplies(Not(BRCA2 binds with RAD51 homolog 1), RAD51 homolog 1 is involved in HRR in humans)\\n--------\\nImplies(Not(A), B)\\nImplies(Not(BRCA2 is involved in HRR in humans), RAD51 homolog 1 is involved in HRR in humans)\\n--------\\nImplies(D, A)\\nImplies(the joining of undamaged homologous molecules is catalyzed, BRCA2 is involved in HRR in humans)\\n--------\\nImplies(Not(A), C)\\nImplies(Not(BRCA2 is involved in HRR in humans), BRCA2 binds with RAD51 homolog 1)\\n--------\\nImplies(Not(C), A)\\nImplies(Not(BRCA2 binds with RAD51 homolog 1), BRCA2 is involved in HRR in humans)\\n--------\\nImplies(Not(A), A)\\nImplies(Not(BRCA2 is involved in HRR in humans), BRCA2 is involved in HRR in humans)\\n--------\\nImplies(Not(B), D)\\nImplies(Not(RAD51 homolog 1 is involved in HRR in humans), the joining of undamaged homologous molecules is catalyzed)\\n--------\\nImplies(Not(B), Not(A))\\nImplies(Not(RAD51 homolog 1 is involved in HRR in humans), Not(BRCA2 is involved in HRR in humans))\\n--------\\nImplies(A, B)\\nImplies(BRCA2 is involved in HRR in humans, RAD51 homolog 1 is involved in HRR in humans)\\n--------\\nImplies(B, A)\\nImplies(RAD51 homolog 1 is involved in HRR in humans, BRCA2 is involved in HRR in humans)\\n--------\\nImplies(Not(A), D)\\nImplies(Not(BRCA2 is involved in HRR in humans), the joining of undamaged homologous molecules is catalyzed)\\n--------\\nImplies(Not(D), B)\\nImplies(Not(the joining of undamaged homologous molecules is catalyzed), RAD51 homolog 1 is involved in HRR in humans)\\n--------\\nImplies(Not(B), Not(D))\\nImplies(Not(RAD51 homolog 1 is involved in HRR in humans), Not(the joining of undamaged homologous molecules is catalyzed))\\n--------\\nImplies(Not(A), Not(B))\\nImplies(Not(BRCA2 is involved in HRR in humans), Not(RAD51 homolog 1 is involved in HRR in humans))\\n--------\\nImplies(Not(D), A)\\nImplies(Not(the joining of undamaged homologous molecules is catalyzed), BRCA2 is involved in HRR in humans)\\n--------\\nImplies(C, B)\\nImplies(BRCA2 binds with RAD51 homolog 1, RAD51 homolog 1 is involved in HRR in humans)\\n--------\\nImplies(Not(B), Not(C))\\nImplies(Not(RAD51 homolog 1 is involved in HRR in humans), Not(BRCA2 binds with RAD51 homolog 1))\\n--------\\nImplies(Not(B), B)\\nImplies(Not(RAD51 homolog 1 is involved in HRR in humans), RAD51 homolog 1 is involved in HRR in humans)\\n--------\\nImplies(C, A)\\nImplies(BRCA2 binds with RAD51 homolog 1, BRCA2 is involved in HRR in humans)\\n--------\\nImplies(Not(B), C)\\nImplies(Not(RAD51 homolog 1 is involved in HRR in humans), BRCA2 binds with RAD51 homolog 1)\\n--------\\n'}",
            "3 iteration: {'syntactic validity': False, 'error code': '', 'solving time': 8.84236741065979, 'proof tactics': ['Type unification failed: Clash of types \"event\" and \"entity\"\\n\\nType error in application: incompatible operand type\\n\\nOperator:  Patient e2 :: entity \\\\<Rightarrow> bool\\nOperand:   e1 :: event\\n', 'No proof state', 'Bad context for command \"oops\"\\\\<^here> -- using reset state'], 'code': 'theory clinical_58_3\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  BRCA2 :: \"entity \u21d2 bool\"\\n  RAD51 :: \"entity \u21d2 bool\"\\n  HRR :: \"entity \u21d2 bool\"\\n  Human :: \"entity \u21d2 bool\"\\n  Involved :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  In :: \"event \u21d2 entity \u21d2 bool\"\\n  Molecules :: \"entity \u21d2 bool\"\\n  Undamaged :: \"entity \u21d2 bool\"\\n  Homologous :: \"entity \u21d2 bool\"\\n  Binding :: \"event \u21d2 bool\"\\n  Joining :: \"event \u21d2 bool\"\\n  Catalyze :: \"event \u21d2 event \u21d2 bool\"\\n  Promote :: \"event \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  Via :: \"event \u21d2 entity \u21d2 bool\"\\n  Repair :: \"entity \u21d2 bool\"\\n\\n(* Explanation 1: BRCA2 and RAD51 homolog 1 are both involved in HRR in humans. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y z e. BRCA2 x \u2227 RAD51 y \u2227 HRR z \u2227 Human z \u2227 Involved e \u2227 Agent e x \u2227 Agent e y \u2227 In e z\"\\n\\n(* Explanation 2: The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z e1 e2. BRCA2 x \u2227 RAD51 y \u2227 Molecules z \u2227 Undamaged z \u2227 Homologous z \u2227 Binding e1 \u2227 Agent e1 x \u2227 Agent e1 y \u2227 Joining e2 \u2227 Agent e2 z \u2227 Catalyze e1 e2\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"BRCA2 x \u2227 Molecules y \u2227 RAD51 z \u2227 Human z \u2227 Undamaged y \u2227 Homologous y \u2227 Repair y\"\\n  (* Hypothesis: BRCA2 promotes the joining of undamaged homologous repair molecules via RAD51 homolog 1 in humans. *)\\n  shows \"\u2203x y z e1 e2. BRCA2 x \u2227 Molecules y \u2227 RAD51 z \u2227 Human z \u2227 Undamaged y \u2227 Homologous y \u2227 Repair y \u2227 Joining e1 \u2227 Agent e1 y \u2227 Promote e2 \u2227 Agent e2 x \u2227 Patient e2 e1 \u2227 Via e2 z \u2227 In e2 z\"\\nproof -\\n  (* From the known information, we have BRCA2 x, Molecules y, RAD51 z, Human z, Undamaged y, Homologous y, and Repair y. *)\\n  from asm have \"BRCA2 x \u2227 Molecules y \u2227 RAD51 z \u2227 Human z \u2227 Undamaged y \u2227 Homologous y \u2227 Repair y\" <ATP>\\n  \\n  (* Explanation 2 states that the binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules. *)\\n  (* We have BRCA2 x and RAD51 z, so we can infer the binding event and the catalysis of the joining event. *)\\n  from explanation_2 have \"\u2203e1 e2. Binding e1 \u2227 Agent e1 x \u2227 Agent e1 z \u2227 Joining e2 \u2227 Agent e2 y \u2227 Catalyze e1 e2\" <ATP>\\n  \\n  (* From the catalysis, we can infer that the joining event occurs, and BRCA2 promotes this joining via RAD51. *)\\n  then have \"Joining e1 \u2227 Agent e1 y \u2227 Promote e2 \u2227 Agent e2 x \u2227 Patient e2 e1 \u2227 Via e2 z \u2227 In e2 z\" <ATP>\\n  \\n  (* Therefore, we can conclude the hypothesis. *)\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: BRCA2 is involved in HRR in humans (from Explanatory Sentence 1)\\nB: RAD51 homolog 1 is involved in HRR in humans (from Explanatory Sentence 1)\\nC: BRCA2 binds with RAD51 homolog 1 (from Explanatory Sentence 2)\\nD: catalyzes the joining of undamaged homologous molecules (from Explanatory Sentence 2)\\n\\nLogical Relations:\\nAnd(A, B)\\nA & B\\n--------\\nImplies(C, D)\\nImplies(BRCA2 binds with RAD51 homolog 1, catalyzes the joining of undamaged homologous molecules)\\n--------\\n\\nDerived Implications:\\nImplies(Not(B), A)\\nImplies(Not(RAD51 homolog 1 is involved in HRR in humans), BRCA2 is involved in HRR in humans)\\n--------\\nImplies(Not(A), Not(D))\\nImplies(Not(BRCA2 is involved in HRR in humans), Not(catalyzes the joining of undamaged homologous molecules))\\n--------\\nImplies(D, B)\\nImplies(catalyzes the joining of undamaged homologous molecules, RAD51 homolog 1 is involved in HRR in humans)\\n--------\\nImplies(Not(A), Not(C))\\nImplies(Not(BRCA2 is involved in HRR in humans), Not(BRCA2 binds with RAD51 homolog 1))\\n--------\\nImplies(Not(C), B)\\nImplies(Not(BRCA2 binds with RAD51 homolog 1), RAD51 homolog 1 is involved in HRR in humans)\\n--------\\nImplies(Not(A), B)\\nImplies(Not(BRCA2 is involved in HRR in humans), RAD51 homolog 1 is involved in HRR in humans)\\n--------\\nImplies(D, A)\\nImplies(catalyzes the joining of undamaged homologous molecules, BRCA2 is involved in HRR in humans)\\n--------\\nImplies(Not(A), C)\\nImplies(Not(BRCA2 is involved in HRR in humans), BRCA2 binds with RAD51 homolog 1)\\n--------\\nImplies(Not(C), A)\\nImplies(Not(BRCA2 binds with RAD51 homolog 1), BRCA2 is involved in HRR in humans)\\n--------\\nImplies(Not(A), A)\\nImplies(Not(BRCA2 is involved in HRR in humans), BRCA2 is involved in HRR in humans)\\n--------\\nImplies(Not(B), D)\\nImplies(Not(RAD51 homolog 1 is involved in HRR in humans), catalyzes the joining of undamaged homologous molecules)\\n--------\\nImplies(Not(B), Not(A))\\nImplies(Not(RAD51 homolog 1 is involved in HRR in humans), Not(BRCA2 is involved in HRR in humans))\\n--------\\nImplies(A, B)\\nImplies(BRCA2 is involved in HRR in humans, RAD51 homolog 1 is involved in HRR in humans)\\n--------\\nImplies(B, A)\\nImplies(RAD51 homolog 1 is involved in HRR in humans, BRCA2 is involved in HRR in humans)\\n--------\\nImplies(Not(A), D)\\nImplies(Not(BRCA2 is involved in HRR in humans), catalyzes the joining of undamaged homologous molecules)\\n--------\\nImplies(Not(D), B)\\nImplies(Not(catalyzes the joining of undamaged homologous molecules), RAD51 homolog 1 is involved in HRR in humans)\\n--------\\nImplies(Not(B), Not(D))\\nImplies(Not(RAD51 homolog 1 is involved in HRR in humans), Not(catalyzes the joining of undamaged homologous molecules))\\n--------\\nImplies(Not(A), Not(B))\\nImplies(Not(BRCA2 is involved in HRR in humans), Not(RAD51 homolog 1 is involved in HRR in humans))\\n--------\\nImplies(Not(D), A)\\nImplies(Not(catalyzes the joining of undamaged homologous molecules), BRCA2 is involved in HRR in humans)\\n--------\\nImplies(C, B)\\nImplies(BRCA2 binds with RAD51 homolog 1, RAD51 homolog 1 is involved in HRR in humans)\\n--------\\nImplies(Not(B), Not(C))\\nImplies(Not(RAD51 homolog 1 is involved in HRR in humans), Not(BRCA2 binds with RAD51 homolog 1))\\n--------\\nImplies(Not(B), B)\\nImplies(Not(RAD51 homolog 1 is involved in HRR in humans), RAD51 homolog 1 is involved in HRR in humans)\\n--------\\nImplies(C, A)\\nImplies(BRCA2 binds with RAD51 homolog 1, BRCA2 is involved in HRR in humans)\\n--------\\nImplies(Not(B), C)\\nImplies(Not(RAD51 homolog 1 is involved in HRR in humans), BRCA2 binds with RAD51 homolog 1)\\n--------\\n'}",
            "4 iteration: {'syntactic validity': False, 'error code': '', 'solving time': 7.49180793762207, 'proof tactics': ['Type unification failed: Clash of types \"entity\" and \"event\"\\n\\nType error in application: incompatible operand type\\n\\nOperator:  Promote :: event \\\\<Rightarrow> bool\\nOperand:   e1 :: entity\\n', 'No proof state', 'Bad context for command \"oops\"\\\\<^here> -- using reset state'], 'code': 'theory clinical_58_4\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  BRCA2 :: \"entity \u21d2 bool\"\\n  RAD51 :: \"entity \u21d2 bool\"\\n  HRR :: \"entity \u21d2 bool\"\\n  Human :: \"entity \u21d2 bool\"\\n  Involved :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  In :: \"event \u21d2 entity \u21d2 bool\"\\n  Molecules :: \"entity \u21d2 bool\"\\n  Binding :: \"event \u21d2 bool\"\\n  Joining :: \"event \u21d2 bool\"\\n  Undamaged :: \"entity \u21d2 bool\"\\n  Homologous :: \"entity \u21d2 bool\"\\n  Catalyze :: \"event \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  Promote :: \"event \u21d2 bool\"\\n  Via :: \"event \u21d2 entity \u21d2 bool\"\\n  Repair :: \"entity \u21d2 bool\"\\n\\n(* Explanation 1: BRCA2 and RAD51 homolog 1 are both involved in HRR in humans. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y z e. BRCA2 x \u2227 RAD51 y \u2227 HRR z \u2227 Human z \u2227 Involved e \u2227 Agent e x \u2227 Agent e y \u2227 In e z\"\\n\\n(* Explanation 2: The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z e1 e2. BRCA2 x \u2227 RAD51 y \u2227 Molecules z \u2227 Binding e1 \u2227 Joining e2 \u2227 Undamaged z \u2227 Homologous z \u2227 Catalyze e1 \u2227 Agent e1 x \u2227 Agent e1 y \u2227 Patient e1 z \u2227 Patient e2 z\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"BRCA2 x \u2227 Molecules y \u2227 RAD51 z \u2227 Human e1\"\\n  (* Hypothesis: BRCA2 promotes the joining of undamaged homologous repair molecules via RAD51 homolog 1 in humans. *)\\n  shows \"\u2203x y z e1 e2. BRCA2 x \u2227 Molecules y \u2227 RAD51 z \u2227 Human e1 \u2227 Joining e2 \u2227 Undamaged y \u2227 Homologous y \u2227 Repair y \u2227 Promote e1 \u2227 Agent e1 x \u2227 Patient e1 e2 \u2227 Via e2 z \u2227 In e2 e1\"\\nproof -\\n  (* From the known information, we have BRCA2 x, Molecules y, RAD51 z, and Human e1. *)\\n  from asm have \"BRCA2 x \u2227 Molecules y \u2227 RAD51 z \u2227 Human e1\" <ATP>\\n  \\n  (* Explanation 1 states that BRCA2 and RAD51 homolog 1 are both involved in HRR in humans. *)\\n  (* Explanation 2 states that the binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules. *)\\n  (* We have logical relation Implies(C, D), which means the binding of BRCA2 and RAD51 homolog 1 implies the joining of undamaged homologous molecules is catalyzed. *)\\n  \\n  (* From explanation_2, we can infer the existence of a binding event e1 and a joining event e2. *)\\n  from explanation_2 obtain e1 e2 where\\n    \"Binding e1 \u2227 Joining e2 \u2227 Catalyze e1 \u2227 Agent e1 x \u2227 Agent e1 z \u2227 Patient e1 y \u2227 Patient e2 y\" <ATP>\\n  \\n  (* Since the joining is catalyzed, we can infer that the joining event e2 involves undamaged homologous molecules. *)\\n  then have \"Joining e2 \u2227 Undamaged y \u2227 Homologous y\" <ATP>\\n  \\n  (* We need to show that BRCA2 promotes the joining of undamaged homologous repair molecules via RAD51 homolog 1 in humans. *)\\n  (* This involves showing that the joining event e2 is promoted by BRCA2 and involves RAD51 as an agent. *)\\n  (* We can use the derived implication Implies(D, B) to show that the catalyzed joining implies RAD51 is involved. *)\\n  from `Joining e2 \u2227 Undamaged y \u2227 Homologous y` have \"RAD51 z\" <ATP>\\n  \\n  (* Finally, we need to show that the joining is promoted by BRCA2 and involves RAD51 via the event e2. *)\\n  have \"Promote e1 \u2227 Agent e1 x \u2227 Patient e1 e2 \u2227 Via e2 z \u2227 In e2 e1\" <ATP>\\n  \\n  (* Therefore, we have shown the hypothesis. *)\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: BRCA2 is involved in HRR in humans (from Explanatory Sentence 1)\\nB: RAD51 homolog 1 is involved in HRR in humans (from Explanatory Sentence 1)\\nC: BRCA2 binds with RAD51 homolog 1 (from Explanatory Sentence 2)\\nD: the joining of undamaged homologous molecules is catalyzed (from Explanatory Sentence 2)\\n\\nLogical Relations:\\nAnd(A, B)\\nA & B\\n--------\\nImplies(C, D)\\nImplies(BRCA2 binds with RAD51 homolog 1, the joining of undamaged homologous molecules is catalyzed)\\n--------\\n\\nDerived Implications:\\nImplies(Not(B), A)\\nImplies(Not(RAD51 homolog 1 is involved in HRR in humans), BRCA2 is involved in HRR in humans)\\n--------\\nImplies(Not(A), Not(D))\\nImplies(Not(BRCA2 is involved in HRR in humans), Not(the joining of undamaged homologous molecules is catalyzed))\\n--------\\nImplies(D, B)\\nImplies(the joining of undamaged homologous molecules is catalyzed, RAD51 homolog 1 is involved in HRR in humans)\\n--------\\nImplies(Not(A), Not(C))\\nImplies(Not(BRCA2 is involved in HRR in humans), Not(BRCA2 binds with RAD51 homolog 1))\\n--------\\nImplies(Not(C), B)\\nImplies(Not(BRCA2 binds with RAD51 homolog 1), RAD51 homolog 1 is involved in HRR in humans)\\n--------\\nImplies(Not(A), B)\\nImplies(Not(BRCA2 is involved in HRR in humans), RAD51 homolog 1 is involved in HRR in humans)\\n--------\\nImplies(D, A)\\nImplies(the joining of undamaged homologous molecules is catalyzed, BRCA2 is involved in HRR in humans)\\n--------\\nImplies(Not(A), C)\\nImplies(Not(BRCA2 is involved in HRR in humans), BRCA2 binds with RAD51 homolog 1)\\n--------\\nImplies(Not(C), A)\\nImplies(Not(BRCA2 binds with RAD51 homolog 1), BRCA2 is involved in HRR in humans)\\n--------\\nImplies(Not(A), A)\\nImplies(Not(BRCA2 is involved in HRR in humans), BRCA2 is involved in HRR in humans)\\n--------\\nImplies(Not(B), D)\\nImplies(Not(RAD51 homolog 1 is involved in HRR in humans), the joining of undamaged homologous molecules is catalyzed)\\n--------\\nImplies(Not(B), Not(A))\\nImplies(Not(RAD51 homolog 1 is involved in HRR in humans), Not(BRCA2 is involved in HRR in humans))\\n--------\\nImplies(A, B)\\nImplies(BRCA2 is involved in HRR in humans, RAD51 homolog 1 is involved in HRR in humans)\\n--------\\nImplies(B, A)\\nImplies(RAD51 homolog 1 is involved in HRR in humans, BRCA2 is involved in HRR in humans)\\n--------\\nImplies(Not(A), D)\\nImplies(Not(BRCA2 is involved in HRR in humans), the joining of undamaged homologous molecules is catalyzed)\\n--------\\nImplies(Not(D), B)\\nImplies(Not(the joining of undamaged homologous molecules is catalyzed), RAD51 homolog 1 is involved in HRR in humans)\\n--------\\nImplies(Not(B), Not(D))\\nImplies(Not(RAD51 homolog 1 is involved in HRR in humans), Not(the joining of undamaged homologous molecules is catalyzed))\\n--------\\nImplies(Not(A), Not(B))\\nImplies(Not(BRCA2 is involved in HRR in humans), Not(RAD51 homolog 1 is involved in HRR in humans))\\n--------\\nImplies(Not(D), A)\\nImplies(Not(the joining of undamaged homologous molecules is catalyzed), BRCA2 is involved in HRR in humans)\\n--------\\nImplies(C, B)\\nImplies(BRCA2 binds with RAD51 homolog 1, RAD51 homolog 1 is involved in HRR in humans)\\n--------\\nImplies(Not(B), Not(C))\\nImplies(Not(RAD51 homolog 1 is involved in HRR in humans), Not(BRCA2 binds with RAD51 homolog 1))\\n--------\\nImplies(Not(B), B)\\nImplies(Not(RAD51 homolog 1 is involved in HRR in humans), RAD51 homolog 1 is involved in HRR in humans)\\n--------\\nImplies(C, A)\\nImplies(BRCA2 binds with RAD51 homolog 1, BRCA2 is involved in HRR in humans)\\n--------\\nImplies(Not(B), C)\\nImplies(Not(RAD51 homolog 1 is involved in HRR in humans), BRCA2 binds with RAD51 homolog 1)\\n--------\\n'}",
            "5 iteration: {'syntactic validity': True, 'error code': '(* Explanation 2 provides that the binding of BRCA2 and RAD51 catalyzes the joining of undamaged homologous molecules. *)\\n(* This implies that the joining of undamaged homologous molecules is catalyzed, which is related to logical proposition D. *)\\n(* We can use the logical relation Implies(C, D) to infer the joining of undamaged homologous molecules. *)\\nfrom explanation_2 have \"\u2203e2. Joining e2 \u2227 Undamaged y \u2227 Homologous y \u2227 Catalyze e1 \u2227 Agent e1 x \u2227 Agent e1 z \u2227 Patient e1 e2\" sledgehammer', 'solving time': 103.28148198127747, 'proof tactics': [], 'code': 'theory clinical_58_5\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  BRCA2 :: \"entity \u21d2 bool\"\\n  RAD51 :: \"entity \u21d2 bool\"\\n  HRR :: \"event \u21d2 bool\"\\n  Human :: \"event \u21d2 bool\"\\n  Involved :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Molecules :: \"entity \u21d2 bool\"\\n  Binding :: \"event \u21d2 bool\"\\n  Joining :: \"event \u21d2 bool\"\\n  Undamaged :: \"entity \u21d2 bool\"\\n  Homologous :: \"entity \u21d2 bool\"\\n  Catalyze :: \"event \u21d2 bool\"\\n  Patient :: \"event \u21d2 event \u21d2 bool\"\\n  Promote :: \"event \u21d2 bool\"\\n  Via :: \"event \u21d2 entity \u21d2 bool\"\\n  In :: \"event \u21d2 event \u21d2 bool\"\\n  Repair :: \"entity \u21d2 bool\"\\n\\n(* Explanation 1: BRCA2 and RAD51 homolog 1 are both involved in HRR in humans. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y e. BRCA2 x \u2227 RAD51 y \u2227 HRR e \u2227 Human e \u2227 Involved e \u2227 Agent e x \u2227 Agent e y\"\\n\\n(* Explanation 2: The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z e1 e2. BRCA2 x \u2227 RAD51 y \u2227 Molecules z \u2227 Binding e1 \u2227 Joining e2 \u2227 Undamaged z \u2227 Homologous z \u2227 Catalyze e1 \u2227 Agent e1 x \u2227 Agent e1 y \u2227 Patient e1 e2\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"BRCA2 x \u2227 Molecules y \u2227 RAD51 z \u2227 Human e1\"\\n  (* Hypothesis: BRCA2 promotes the joining of undamaged homologous repair molecules via RAD51 homolog 1 in humans. *)\\n  shows \"\u2203x y z e1 e2. BRCA2 x \u2227 Molecules y \u2227 RAD51 z \u2227 Human e1 \u2227 Joining e2 \u2227 Undamaged y \u2227 Homologous y \u2227 Repair y \u2227 Promote e1 \u2227 Agent e1 x \u2227 Patient e1 e2 \u2227 Via e1 z \u2227 In e1 e2\"\\nproof -\\n  (* From the premise, we have known information about BRCA2, Molecules, RAD51, and Human. *)\\n  from asm have \"BRCA2 x \u2227 Molecules y \u2227 RAD51 z \u2227 Human e1\" <ATP>\\n  (* Explanation 2 provides that the binding of BRCA2 and RAD51 catalyzes the joining of undamaged homologous molecules. *)\\n  (* This implies that the joining of undamaged homologous molecules is catalyzed, which is related to logical proposition D. *)\\n  (* We can use the logical relation Implies(C, D) to infer the joining of undamaged homologous molecules. *)\\n  from explanation_2 have \"\u2203e2. Joining e2 \u2227 Undamaged y \u2227 Homologous y \u2227 Catalyze e1 \u2227 Agent e1 x \u2227 Agent e1 z \u2227 Patient e1 e2\" <ATP>\\n  (* Since the joining is catalyzed, we can infer that BRCA2 promotes the joining via RAD51 in humans. *)\\n  (* We can conclude the hypothesis by showing the existence of such entities and events. *)\\n  then have \"\u2203x y z e1 e2. BRCA2 x \u2227 Molecules y \u2227 RAD51 z \u2227 Human e1 \u2227 Joining e2 \u2227 Undamaged y \u2227 Homologous y \u2227 Repair y \u2227 Promote e1 \u2227 Agent e1 x \u2227 Patient e1 e2 \u2227 Via e1 z \u2227 In e1 e2\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: BRCA2 is involved in HRR in humans (from Explanatory Sentence 1)\\nB: RAD51 homolog 1 is involved in HRR in humans (from Explanatory Sentence 1)\\nC: BRCA2 binds with RAD51 homolog 1 (from Explanatory Sentence 2)\\nD: the joining of undamaged homologous molecules is catalyzed (from Explanatory Sentence 2)\\n\\nLogical Relations:\\nAnd(A, B)\\nA & B\\n--------\\nImplies(C, D)\\nImplies(BRCA2 binds with RAD51 homolog 1, the joining of undamaged homologous molecules is catalyzed)\\n--------\\n\\nDerived Implications:\\nImplies(Not(B), A)\\nImplies(Not(RAD51 homolog 1 is involved in HRR in humans), BRCA2 is involved in HRR in humans)\\n--------\\nImplies(Not(A), Not(D))\\nImplies(Not(BRCA2 is involved in HRR in humans), Not(the joining of undamaged homologous molecules is catalyzed))\\n--------\\nImplies(D, B)\\nImplies(the joining of undamaged homologous molecules is catalyzed, RAD51 homolog 1 is involved in HRR in humans)\\n--------\\nImplies(Not(A), Not(C))\\nImplies(Not(BRCA2 is involved in HRR in humans), Not(BRCA2 binds with RAD51 homolog 1))\\n--------\\nImplies(Not(C), B)\\nImplies(Not(BRCA2 binds with RAD51 homolog 1), RAD51 homolog 1 is involved in HRR in humans)\\n--------\\nImplies(Not(A), B)\\nImplies(Not(BRCA2 is involved in HRR in humans), RAD51 homolog 1 is involved in HRR in humans)\\n--------\\nImplies(D, A)\\nImplies(the joining of undamaged homologous molecules is catalyzed, BRCA2 is involved in HRR in humans)\\n--------\\nImplies(Not(A), C)\\nImplies(Not(BRCA2 is involved in HRR in humans), BRCA2 binds with RAD51 homolog 1)\\n--------\\nImplies(Not(C), A)\\nImplies(Not(BRCA2 binds with RAD51 homolog 1), BRCA2 is involved in HRR in humans)\\n--------\\nImplies(Not(A), A)\\nImplies(Not(BRCA2 is involved in HRR in humans), BRCA2 is involved in HRR in humans)\\n--------\\nImplies(Not(B), D)\\nImplies(Not(RAD51 homolog 1 is involved in HRR in humans), the joining of undamaged homologous molecules is catalyzed)\\n--------\\nImplies(Not(B), Not(A))\\nImplies(Not(RAD51 homolog 1 is involved in HRR in humans), Not(BRCA2 is involved in HRR in humans))\\n--------\\nImplies(A, B)\\nImplies(BRCA2 is involved in HRR in humans, RAD51 homolog 1 is involved in HRR in humans)\\n--------\\nImplies(B, A)\\nImplies(RAD51 homolog 1 is involved in HRR in humans, BRCA2 is involved in HRR in humans)\\n--------\\nImplies(Not(A), D)\\nImplies(Not(BRCA2 is involved in HRR in humans), the joining of undamaged homologous molecules is catalyzed)\\n--------\\nImplies(Not(D), B)\\nImplies(Not(the joining of undamaged homologous molecules is catalyzed), RAD51 homolog 1 is involved in HRR in humans)\\n--------\\nImplies(Not(B), Not(D))\\nImplies(Not(RAD51 homolog 1 is involved in HRR in humans), Not(the joining of undamaged homologous molecules is catalyzed))\\n--------\\nImplies(Not(A), Not(B))\\nImplies(Not(BRCA2 is involved in HRR in humans), Not(RAD51 homolog 1 is involved in HRR in humans))\\n--------\\nImplies(Not(D), A)\\nImplies(Not(the joining of undamaged homologous molecules is catalyzed), BRCA2 is involved in HRR in humans)\\n--------\\nImplies(C, B)\\nImplies(BRCA2 binds with RAD51 homolog 1, RAD51 homolog 1 is involved in HRR in humans)\\n--------\\nImplies(Not(B), Not(C))\\nImplies(Not(RAD51 homolog 1 is involved in HRR in humans), Not(BRCA2 binds with RAD51 homolog 1))\\n--------\\nImplies(Not(B), B)\\nImplies(Not(RAD51 homolog 1 is involved in HRR in humans), RAD51 homolog 1 is involved in HRR in humans)\\n--------\\nImplies(C, A)\\nImplies(BRCA2 binds with RAD51 homolog 1, BRCA2 is involved in HRR in humans)\\n--------\\nImplies(Not(B), C)\\nImplies(Not(RAD51 homolog 1 is involved in HRR in humans), BRCA2 binds with RAD51 homolog 1)\\n--------\\n'}",
            "6 iteration: {'syntactic validity': False, 'error code': '', 'solving time': 8.938815116882324, 'proof tactics': ['Type unification failed: Clash of types \"event\" and \"entity\"\\n\\nType error in application: incompatible operand type\\n\\nOperator:  In :: entity \\\\<Rightarrow> entity \\\\<Rightarrow> bool\\nOperand:   e2 :: event\\n', 'No proof state', 'Bad context for command \"oops\"\\\\<^here> -- using reset state'], 'code': 'theory clinical_58_6\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  BRCA2 :: \"entity \u21d2 bool\"\\n  RAD51 :: \"entity \u21d2 bool\"\\n  HRR :: \"entity \u21d2 bool\"\\n  Human :: \"entity \u21d2 bool\"\\n  Involved :: \"entity \u21d2 entity \u21d2 bool\"\\n  In :: \"entity \u21d2 entity \u21d2 bool\"\\n  Molecules :: \"entity \u21d2 bool\"\\n  Binding :: \"event \u21d2 bool\"\\n  Joining :: \"event \u21d2 bool\"\\n  Catalyze :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  Undamaged :: \"entity \u21d2 bool\"\\n  Homologous :: \"entity \u21d2 bool\"\\n  Promote :: \"event \u21d2 bool\"\\n  Via :: \"event \u21d2 entity \u21d2 bool\"\\n  Repair :: \"entity \u21d2 bool\"\\n\\n(* Explanation 1: BRCA2 and RAD51 homolog 1 are both involved in homologous recombination repair (HRR) in humans. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y z e. BRCA2 x \u2227 RAD51 y \u2227 HRR z \u2227 Human e \u2227 Involved x z \u2227 Involved y z \u2227 In z e\"\\n\\n(* Explanation 2: The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules, and this process is promoted by BRCA2 via RAD51 homolog 1 in humans. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z w e1 e2 e3. BRCA2 x \u2227 RAD51 y \u2227 Molecules z \u2227 Human w \u2227 Binding e1 \u2227 Joining e2 \u2227 Catalyze e1 \u2227 Agent e1 x \u2227 Agent e1 y \u2227 Patient e1 z \u2227 Undamaged z \u2227 Homologous z \u2227 Promote e3 \u2227 Agent e3 x \u2227 Patient e3 z \u2227 Via e3 y \u2227 In w w\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"BRCA2 x \u2227 Molecules y \u2227 RAD51 z \u2227 Human e1\"\\n  (* Hypothesis: BRCA2 promotes the joining of undamaged homologous repair molecules via RAD51 homolog 1 in humans. *)\\n  shows \"\u2203x y z e1 e2. BRCA2 x \u2227 Molecules y \u2227 RAD51 z \u2227 Human e1 \u2227 Joining e2 \u2227 Undamaged y \u2227 Homologous y \u2227 Repair y \u2227 Promote e2 \u2227 Agent e2 x \u2227 Patient e2 y \u2227 Via e2 z \u2227 In e2 e1\"\\nproof -\\n  (* From the assumption, we have the known information about BRCA2, Molecules, RAD51, and Human. *)\\n  from asm have \"BRCA2 x \u2227 Molecules y \u2227 RAD51 z \u2227 Human e1\" <ATP>\\n  (* Explanation 2 provides that the binding of BRCA2 and RAD51 catalyzes the joining of undamaged homologous molecules. *)\\n  (* This is captured in the logical relation Implies(C, D). *)\\n  (* We can infer that the process is promoted by BRCA2 via RAD51 homolog 1 in humans. *)\\n  then have \"Joining e2 \u2227 Undamaged y \u2227 Homologous y \u2227 Promote e2 \u2227 Agent e2 x \u2227 Patient e2 y \u2227 Via e2 z \u2227 In e2 e1\" <ATP>\\n  (* Therefore, we can conclude the hypothesis. *)\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: BRCA2 is involved in homologous recombination repair (HRR) in humans (from Explanatory Sentence 1)\\nB: RAD51 homolog 1 is involved in homologous recombination repair (HRR) in humans (from Explanatory Sentence 1)\\nC: The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules (from Explanatory Sentence 2)\\nD: The process is promoted by BRCA2 via RAD51 homolog 1 in humans (from Explanatory Sentence 2)\\n\\nLogical Relations:\\nAnd(A, B)\\nA & B\\n--------\\nImplies(And(A, B), C)\\nImplies(A & B, The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules)\\n--------\\nImplies(C, D)\\nImplies(The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules, The process is promoted by BRCA2 via RAD51 homolog 1 in humans)\\n--------\\n\\nDerived Implications:\\nImplies(Not(B), A)\\nImplies(Not(RAD51 homolog 1 is involved in homologous recombination repair  in humans), BRCA2 is involved in homologous recombination repair  in humans)\\n--------\\nImplies(Not(C), Not(D))\\nImplies(Not(The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules), Not(The process is promoted by BRCA2 via RAD51 homolog 1 in humans))\\n--------\\nImplies(Not(A), Not(D))\\nImplies(Not(BRCA2 is involved in homologous recombination repair  in humans), Not(The process is promoted by BRCA2 via RAD51 homolog 1 in humans))\\n--------\\nImplies(D, B)\\nImplies(The process is promoted by BRCA2 via RAD51 homolog 1 in humans, RAD51 homolog 1 is involved in homologous recombination repair  in humans)\\n--------\\nImplies(Not(D), D)\\nImplies(Not(The process is promoted by BRCA2 via RAD51 homolog 1 in humans), The process is promoted by BRCA2 via RAD51 homolog 1 in humans)\\n--------\\nImplies(D, C)\\nImplies(The process is promoted by BRCA2 via RAD51 homolog 1 in humans, The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules)\\n--------\\nImplies(Not(A), Not(C))\\nImplies(Not(BRCA2 is involved in homologous recombination repair  in humans), Not(The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules))\\n--------\\nImplies(Not(C), B)\\nImplies(Not(The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules), RAD51 homolog 1 is involved in homologous recombination repair  in humans)\\n--------\\nImplies(Not(A), B)\\nImplies(Not(BRCA2 is involved in homologous recombination repair  in humans), RAD51 homolog 1 is involved in homologous recombination repair  in humans)\\n--------\\nImplies(D, A)\\nImplies(The process is promoted by BRCA2 via RAD51 homolog 1 in humans, BRCA2 is involved in homologous recombination repair  in humans)\\n--------\\nImplies(Not(C), C)\\nImplies(Not(The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules), The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules)\\n--------\\nImplies(Not(A), C)\\nImplies(Not(BRCA2 is involved in homologous recombination repair  in humans), The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules)\\n--------\\nImplies(Not(D), Not(A))\\nImplies(Not(The process is promoted by BRCA2 via RAD51 homolog 1 in humans), Not(BRCA2 is involved in homologous recombination repair  in humans))\\n--------\\nImplies(Not(C), A)\\nImplies(Not(The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules), BRCA2 is involved in homologous recombination repair  in humans)\\n--------\\nImplies(Not(A), A)\\nImplies(Not(BRCA2 is involved in homologous recombination repair  in humans), BRCA2 is involved in homologous recombination repair  in humans)\\n--------\\nImplies(Not(B), D)\\nImplies(Not(RAD51 homolog 1 is involved in homologous recombination repair  in humans), The process is promoted by BRCA2 via RAD51 homolog 1 in humans)\\n--------\\nImplies(Not(D), Not(B))\\nImplies(Not(The process is promoted by BRCA2 via RAD51 homolog 1 in humans), Not(RAD51 homolog 1 is involved in homologous recombination repair  in humans))\\n--------\\nImplies(Not(B), Not(A))\\nImplies(Not(RAD51 homolog 1 is involved in homologous recombination repair  in humans), Not(BRCA2 is involved in homologous recombination repair  in humans))\\n--------\\nImplies(B, C)\\nImplies(RAD51 homolog 1 is involved in homologous recombination repair  in humans, The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules)\\n--------\\nImplies(A, B)\\nImplies(BRCA2 is involved in homologous recombination repair  in humans, RAD51 homolog 1 is involved in homologous recombination repair  in humans)\\n--------\\nImplies(B, A)\\nImplies(RAD51 homolog 1 is involved in homologous recombination repair  in humans, BRCA2 is involved in homologous recombination repair  in humans)\\n--------\\nImplies(A, C)\\nImplies(BRCA2 is involved in homologous recombination repair  in humans, The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules)\\n--------\\nImplies(Not(C), D)\\nImplies(Not(The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules), The process is promoted by BRCA2 via RAD51 homolog 1 in humans)\\n--------\\nImplies(Not(A), D)\\nImplies(Not(BRCA2 is involved in homologous recombination repair  in humans), The process is promoted by BRCA2 via RAD51 homolog 1 in humans)\\n--------\\nImplies(Not(D), B)\\nImplies(Not(The process is promoted by BRCA2 via RAD51 homolog 1 in humans), RAD51 homolog 1 is involved in homologous recombination repair  in humans)\\n--------\\nImplies(Not(C), Not(A))\\nImplies(Not(The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules), Not(BRCA2 is involved in homologous recombination repair  in humans))\\n--------\\nImplies(Not(B), Not(D))\\nImplies(Not(RAD51 homolog 1 is involved in homologous recombination repair  in humans), Not(The process is promoted by BRCA2 via RAD51 homolog 1 in humans))\\n--------\\nImplies(Not(C), Not(B))\\nImplies(Not(The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules), Not(RAD51 homolog 1 is involved in homologous recombination repair  in humans))\\n--------\\nImplies(Not(A), Not(B))\\nImplies(Not(BRCA2 is involved in homologous recombination repair  in humans), Not(RAD51 homolog 1 is involved in homologous recombination repair  in humans))\\n--------\\nImplies(B, D)\\nImplies(RAD51 homolog 1 is involved in homologous recombination repair  in humans, The process is promoted by BRCA2 via RAD51 homolog 1 in humans)\\n--------\\nImplies(Not(D), C)\\nImplies(Not(The process is promoted by BRCA2 via RAD51 homolog 1 in humans), The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules)\\n--------\\nImplies(Not(D), A)\\nImplies(Not(The process is promoted by BRCA2 via RAD51 homolog 1 in humans), BRCA2 is involved in homologous recombination repair  in humans)\\n--------\\nImplies(C, B)\\nImplies(The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules, RAD51 homolog 1 is involved in homologous recombination repair  in humans)\\n--------\\nImplies(Not(B), Not(C))\\nImplies(Not(RAD51 homolog 1 is involved in homologous recombination repair  in humans), Not(The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules))\\n--------\\nImplies(Not(B), B)\\nImplies(Not(RAD51 homolog 1 is involved in homologous recombination repair  in humans), RAD51 homolog 1 is involved in homologous recombination repair  in humans)\\n--------\\nImplies(A, D)\\nImplies(BRCA2 is involved in homologous recombination repair  in humans, The process is promoted by BRCA2 via RAD51 homolog 1 in humans)\\n--------\\nImplies(C, A)\\nImplies(The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules, BRCA2 is involved in homologous recombination repair  in humans)\\n--------\\nImplies(Not(B), C)\\nImplies(Not(RAD51 homolog 1 is involved in homologous recombination repair  in humans), The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules)\\n--------\\n'}",
            "7 iteration: {'syntactic validity': False, 'error code': '', 'solving time': 11.522575855255127, 'proof tactics': ['Type unification failed: Clash of types \"event\" and \"entity\"\\n\\nType error in application: incompatible operand type\\n\\nOperator:  In :: entity \\\\<Rightarrow> entity \\\\<Rightarrow> bool\\nOperand:   e2 :: event\\n', 'No proof state', 'Bad context for command \"oops\"\\\\<^here> -- using reset state'], 'code': 'theory clinical_58_7\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  BRCA2 :: \"entity \u21d2 bool\"\\n  RAD51 :: \"entity \u21d2 bool\"\\n  HRR :: \"entity \u21d2 bool\"\\n  Human :: \"entity \u21d2 bool\"\\n  Involved :: \"entity \u21d2 entity \u21d2 bool\"\\n  In :: \"entity \u21d2 entity \u21d2 bool\"\\n  Molecules :: \"entity \u21d2 bool\"\\n  Binding :: \"event \u21d2 bool\"\\n  Joining :: \"event \u21d2 bool\"\\n  Catalyzes :: \"event \u21d2 event \u21d2 bool\"\\n  Undamaged :: \"entity \u21d2 bool\"\\n  Homologous :: \"entity \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Promoted :: \"event \u21d2 bool\"\\n  Promotes :: \"event \u21d2 bool\"\\n  Means :: \"event \u21d2 entity \u21d2 bool\"\\n\\n(* Explanation 1: BRCA2 and RAD51 homolog 1 are both involved in homologous recombination repair (HRR) in humans. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y z e. BRCA2 x \u2227 RAD51 y \u2227 HRR z \u2227 Human e \u2227 Involved x z \u2227 Involved y z \u2227 In z e\"\\n\\n(* Explanation 2: The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules, and this process is promoted by BRCA2 via RAD51 homolog 1 in humans. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z w e1 e2 e3. BRCA2 x \u2227 RAD51 y \u2227 Molecules z \u2227 Human w \u2227 Binding e1 \u2227 Joining e2 \u2227 Catalyzes e1 e2 \u2227 Undamaged z \u2227 Homologous z \u2227 Agent e2 z \u2227 Promoted e3 \u2227 Agent e3 x \u2227 Means e3 y \u2227 In y w\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"BRCA2 x \u2227 Molecules y \u2227 RAD51 z \u2227 Human e1\"\\n  (* Hypothesis: BRCA2 promotes the joining of undamaged homologous repair molecules via RAD51 homolog 1 in humans. *)\\n  shows \"\u2203x y z e1 e2. BRCA2 x \u2227 Molecules y \u2227 RAD51 z \u2227 Human e1 \u2227 Joining e2 \u2227 Undamaged y \u2227 Homologous y \u2227 Repair y \u2227 Agent e2 y \u2227 Promotes e2 \u2227 Agent e2 x \u2227 Means e2 z \u2227 In e2 e1\"\\nproof -\\n  (* From the premise, we have known information about BRCA2, Molecules, RAD51, and Human. *)\\n  from asm have \"BRCA2 x \u2227 Molecules y \u2227 RAD51 z \u2227 Human e1\" <ATP>\\n  (* Explanation 2 provides that the binding of BRCA2 and RAD51 catalyzes the joining of undamaged homologous molecules, and this process is promoted by BRCA2 via RAD51 in humans. *)\\n  (* We have logical relations: Implies(C, D) and Implies(D, C) *)\\n  (* From explanation_2, we can infer the joining event and its promotion by BRCA2 via RAD51. *)\\n  then have \"Joining e2 \u2227 Undamaged y \u2227 Homologous y \u2227 Agent e2 y \u2227 Promotes e2 \u2227 Agent e2 x \u2227 Means e2 z \u2227 In e2 e1\" <ATP>\\n  (* Therefore, we can conclude the hypothesis. *)\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: BRCA2 is involved in homologous recombination repair (HRR) in humans (from Explanatory Sentence 1)\\nB: RAD51 homolog 1 is involved in homologous recombination repair (HRR) in humans (from Explanatory Sentence 1)\\nC: The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules (from Explanatory Sentence 2)\\nD: The process is promoted by BRCA2 via RAD51 homolog 1 in humans (from Explanatory Sentence 2)\\n\\nLogical Relations:\\nAnd(A, B)\\nA & B\\n--------\\nImplies(And(A, B), C)\\nImplies(A & B, The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules)\\n--------\\nImplies(C, D)\\nImplies(The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules, The process is promoted by BRCA2 via RAD51 homolog 1 in humans)\\n--------\\n\\nDerived Implications:\\nImplies(Not(B), A)\\nImplies(Not(RAD51 homolog 1 is involved in homologous recombination repair  in humans), BRCA2 is involved in homologous recombination repair  in humans)\\n--------\\nImplies(Not(C), Not(D))\\nImplies(Not(The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules), Not(The process is promoted by BRCA2 via RAD51 homolog 1 in humans))\\n--------\\nImplies(Not(A), Not(D))\\nImplies(Not(BRCA2 is involved in homologous recombination repair  in humans), Not(The process is promoted by BRCA2 via RAD51 homolog 1 in humans))\\n--------\\nImplies(D, B)\\nImplies(The process is promoted by BRCA2 via RAD51 homolog 1 in humans, RAD51 homolog 1 is involved in homologous recombination repair  in humans)\\n--------\\nImplies(Not(D), D)\\nImplies(Not(The process is promoted by BRCA2 via RAD51 homolog 1 in humans), The process is promoted by BRCA2 via RAD51 homolog 1 in humans)\\n--------\\nImplies(D, C)\\nImplies(The process is promoted by BRCA2 via RAD51 homolog 1 in humans, The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules)\\n--------\\nImplies(Not(A), Not(C))\\nImplies(Not(BRCA2 is involved in homologous recombination repair  in humans), Not(The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules))\\n--------\\nImplies(Not(C), B)\\nImplies(Not(The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules), RAD51 homolog 1 is involved in homologous recombination repair  in humans)\\n--------\\nImplies(Not(A), B)\\nImplies(Not(BRCA2 is involved in homologous recombination repair  in humans), RAD51 homolog 1 is involved in homologous recombination repair  in humans)\\n--------\\nImplies(D, A)\\nImplies(The process is promoted by BRCA2 via RAD51 homolog 1 in humans, BRCA2 is involved in homologous recombination repair  in humans)\\n--------\\nImplies(Not(C), C)\\nImplies(Not(The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules), The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules)\\n--------\\nImplies(Not(A), C)\\nImplies(Not(BRCA2 is involved in homologous recombination repair  in humans), The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules)\\n--------\\nImplies(Not(D), Not(A))\\nImplies(Not(The process is promoted by BRCA2 via RAD51 homolog 1 in humans), Not(BRCA2 is involved in homologous recombination repair  in humans))\\n--------\\nImplies(Not(C), A)\\nImplies(Not(The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules), BRCA2 is involved in homologous recombination repair  in humans)\\n--------\\nImplies(Not(A), A)\\nImplies(Not(BRCA2 is involved in homologous recombination repair  in humans), BRCA2 is involved in homologous recombination repair  in humans)\\n--------\\nImplies(Not(B), D)\\nImplies(Not(RAD51 homolog 1 is involved in homologous recombination repair  in humans), The process is promoted by BRCA2 via RAD51 homolog 1 in humans)\\n--------\\nImplies(Not(D), Not(B))\\nImplies(Not(The process is promoted by BRCA2 via RAD51 homolog 1 in humans), Not(RAD51 homolog 1 is involved in homologous recombination repair  in humans))\\n--------\\nImplies(Not(B), Not(A))\\nImplies(Not(RAD51 homolog 1 is involved in homologous recombination repair  in humans), Not(BRCA2 is involved in homologous recombination repair  in humans))\\n--------\\nImplies(B, C)\\nImplies(RAD51 homolog 1 is involved in homologous recombination repair  in humans, The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules)\\n--------\\nImplies(A, B)\\nImplies(BRCA2 is involved in homologous recombination repair  in humans, RAD51 homolog 1 is involved in homologous recombination repair  in humans)\\n--------\\nImplies(B, A)\\nImplies(RAD51 homolog 1 is involved in homologous recombination repair  in humans, BRCA2 is involved in homologous recombination repair  in humans)\\n--------\\nImplies(A, C)\\nImplies(BRCA2 is involved in homologous recombination repair  in humans, The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules)\\n--------\\nImplies(Not(C), D)\\nImplies(Not(The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules), The process is promoted by BRCA2 via RAD51 homolog 1 in humans)\\n--------\\nImplies(Not(A), D)\\nImplies(Not(BRCA2 is involved in homologous recombination repair  in humans), The process is promoted by BRCA2 via RAD51 homolog 1 in humans)\\n--------\\nImplies(Not(D), B)\\nImplies(Not(The process is promoted by BRCA2 via RAD51 homolog 1 in humans), RAD51 homolog 1 is involved in homologous recombination repair  in humans)\\n--------\\nImplies(Not(C), Not(A))\\nImplies(Not(The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules), Not(BRCA2 is involved in homologous recombination repair  in humans))\\n--------\\nImplies(Not(B), Not(D))\\nImplies(Not(RAD51 homolog 1 is involved in homologous recombination repair  in humans), Not(The process is promoted by BRCA2 via RAD51 homolog 1 in humans))\\n--------\\nImplies(Not(C), Not(B))\\nImplies(Not(The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules), Not(RAD51 homolog 1 is involved in homologous recombination repair  in humans))\\n--------\\nImplies(Not(A), Not(B))\\nImplies(Not(BRCA2 is involved in homologous recombination repair  in humans), Not(RAD51 homolog 1 is involved in homologous recombination repair  in humans))\\n--------\\nImplies(B, D)\\nImplies(RAD51 homolog 1 is involved in homologous recombination repair  in humans, The process is promoted by BRCA2 via RAD51 homolog 1 in humans)\\n--------\\nImplies(Not(D), C)\\nImplies(Not(The process is promoted by BRCA2 via RAD51 homolog 1 in humans), The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules)\\n--------\\nImplies(Not(D), A)\\nImplies(Not(The process is promoted by BRCA2 via RAD51 homolog 1 in humans), BRCA2 is involved in homologous recombination repair  in humans)\\n--------\\nImplies(C, B)\\nImplies(The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules, RAD51 homolog 1 is involved in homologous recombination repair  in humans)\\n--------\\nImplies(Not(B), Not(C))\\nImplies(Not(RAD51 homolog 1 is involved in homologous recombination repair  in humans), Not(The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules))\\n--------\\nImplies(Not(B), B)\\nImplies(Not(RAD51 homolog 1 is involved in homologous recombination repair  in humans), RAD51 homolog 1 is involved in homologous recombination repair  in humans)\\n--------\\nImplies(A, D)\\nImplies(BRCA2 is involved in homologous recombination repair  in humans, The process is promoted by BRCA2 via RAD51 homolog 1 in humans)\\n--------\\nImplies(C, A)\\nImplies(The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules, BRCA2 is involved in homologous recombination repair  in humans)\\n--------\\nImplies(Not(B), C)\\nImplies(Not(RAD51 homolog 1 is involved in homologous recombination repair  in humans), The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules)\\n--------\\n'}",
            "8 iteration: {'syntactic validity': False, 'error code': '', 'solving time': 10.510272979736328, 'proof tactics': ['Type unification failed: Clash of types \"event\" and \"entity\"\\n\\nType error in application: incompatible operand type\\n\\nOperator:  In :: entity \\\\<Rightarrow> entity \\\\<Rightarrow> bool\\nOperand:   e2 :: event\\n', 'No proof state', 'Bad context for command \"oops\"\\\\<^here> -- using reset state'], 'code': 'theory clinical_58_8\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  BRCA2 :: \"entity \u21d2 bool\"\\n  RAD51 :: \"entity \u21d2 bool\"\\n  HRR :: \"entity \u21d2 bool\"\\n  Human :: \"entity \u21d2 bool\"\\n  InvolvedIn :: \"entity \u21d2 entity \u21d2 bool\"\\n  In :: \"entity \u21d2 entity \u21d2 bool\"\\n  Molecules :: \"entity \u21d2 bool\"\\n  Binding :: \"event \u21d2 bool\"\\n  Joining :: \"event \u21d2 bool\"\\n  Catalyze :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  Undamaged :: \"entity \u21d2 bool\"\\n  Homologous :: \"entity \u21d2 bool\"\\n  Promote :: \"event \u21d2 bool\"\\n  Via :: \"event \u21d2 entity \u21d2 bool\"\\n\\n(* Explanation 1: BRCA2 and RAD51 homolog 1 are both involved in homologous recombination repair (HRR) in humans. *)\\naxiomatization where\\n  explanation_1: \"\u2200x y z e. BRCA2 x \u2227 RAD51 y \u2227 HRR z \u2227 Human e \u27f6 (InvolvedIn x z \u2227 InvolvedIn y z \u2227 In z e)\"\\n\\n(* Explanation 2: The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules, and this process is promoted by BRCA2 via RAD51 homolog 1 in humans. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z w e1 e2 e3. BRCA2 x \u2227 RAD51 y \u2227 Molecules z \u2227 Human w \u2227 Binding e1 \u2227 Joining e2 \u2227 Catalyze e1 \u2227 Agent e1 x \u2227 Agent e1 y \u2227 Patient e1 z \u2227 Undamaged z \u2227 Homologous z \u2227 Promote e3 \u2227 Agent e3 x \u2227 Patient e3 z \u2227 Via e3 y \u2227 In w w\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"BRCA2 x \u2227 Molecules y \u2227 RAD51 z \u2227 Human e1\"\\n  (* Hypothesis: BRCA2 promotes the joining of undamaged homologous repair molecules via RAD51 homolog 1 in humans. *)\\n  shows \"\u2203x y z e1 e2. BRCA2 x \u2227 Molecules y \u2227 RAD51 z \u2227 Human e1 \u2227 Joining e2 \u2227 Undamaged y \u2227 Homologous y \u2227 Repair y \u2227 Promote e2 \u2227 Agent e2 x \u2227 Patient e2 y \u2227 Via e2 z \u2227 In e2 e1\"\\nproof -\\n  (* From the premise, we have known information about BRCA2, Molecules, RAD51, and Human. *)\\n  from asm have \"BRCA2 x \u2227 Molecules y \u2227 RAD51 z \u2227 Human e1\" <ATP>\\n  (* Explanation 2 provides a scenario where the binding of BRCA2 and RAD51 catalyzes the joining of undamaged homologous molecules, and this process is promoted by BRCA2 via RAD51 in humans. *)\\n  (* We can use the logical relation Implies(C, D) to infer that if the binding catalyzes the joining, then the process is promoted by BRCA2 via RAD51. *)\\n  from explanation_2 obtain e2 where \"Joining e2 \u2227 Undamaged y \u2227 Homologous y \u2227 Promote e2 \u2227 Agent e2 x \u2227 Patient e2 y \u2227 Via e2 z \u2227 In e2 e1\" <ATP>\\n  (* Combine the information to show the hypothesis. *)\\n  then have \"\u2203x y z e1 e2. BRCA2 x \u2227 Molecules y \u2227 RAD51 z \u2227 Human e1 \u2227 Joining e2 \u2227 Undamaged y \u2227 Homologous y \u2227 Promote e2 \u2227 Agent e2 x \u2227 Patient e2 y \u2227 Via e2 z \u2227 In e2 e1\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: BRCA2 is involved in homologous recombination repair (HRR) in humans (from Explanatory Sentence 1)\\nB: RAD51 homolog 1 is involved in homologous recombination repair (HRR) in humans (from Explanatory Sentence 1)\\nC: The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules (from Explanatory Sentence 2)\\nD: The process is promoted by BRCA2 via RAD51 homolog 1 in humans (from Explanatory Sentence 2)\\n\\nLogical Relations:\\nAnd(A, B)\\nA & B\\n--------\\nImplies(C, D)\\nImplies(The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules, The process is promoted by BRCA2 via RAD51 homolog 1 in humans)\\n--------\\n\\nDerived Implications:\\nImplies(Not(B), A)\\nImplies(Not(RAD51 homolog 1 is involved in homologous recombination repair  in humans), BRCA2 is involved in homologous recombination repair  in humans)\\n--------\\nImplies(Not(A), Not(D))\\nImplies(Not(BRCA2 is involved in homologous recombination repair  in humans), Not(The process is promoted by BRCA2 via RAD51 homolog 1 in humans))\\n--------\\nImplies(D, B)\\nImplies(The process is promoted by BRCA2 via RAD51 homolog 1 in humans, RAD51 homolog 1 is involved in homologous recombination repair  in humans)\\n--------\\nImplies(Not(A), Not(C))\\nImplies(Not(BRCA2 is involved in homologous recombination repair  in humans), Not(The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules))\\n--------\\nImplies(Not(C), B)\\nImplies(Not(The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules), RAD51 homolog 1 is involved in homologous recombination repair  in humans)\\n--------\\nImplies(Not(A), B)\\nImplies(Not(BRCA2 is involved in homologous recombination repair  in humans), RAD51 homolog 1 is involved in homologous recombination repair  in humans)\\n--------\\nImplies(D, A)\\nImplies(The process is promoted by BRCA2 via RAD51 homolog 1 in humans, BRCA2 is involved in homologous recombination repair  in humans)\\n--------\\nImplies(Not(A), C)\\nImplies(Not(BRCA2 is involved in homologous recombination repair  in humans), The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules)\\n--------\\nImplies(Not(C), A)\\nImplies(Not(The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules), BRCA2 is involved in homologous recombination repair  in humans)\\n--------\\nImplies(Not(A), A)\\nImplies(Not(BRCA2 is involved in homologous recombination repair  in humans), BRCA2 is involved in homologous recombination repair  in humans)\\n--------\\nImplies(Not(B), D)\\nImplies(Not(RAD51 homolog 1 is involved in homologous recombination repair  in humans), The process is promoted by BRCA2 via RAD51 homolog 1 in humans)\\n--------\\nImplies(Not(B), Not(A))\\nImplies(Not(RAD51 homolog 1 is involved in homologous recombination repair  in humans), Not(BRCA2 is involved in homologous recombination repair  in humans))\\n--------\\nImplies(A, B)\\nImplies(BRCA2 is involved in homologous recombination repair  in humans, RAD51 homolog 1 is involved in homologous recombination repair  in humans)\\n--------\\nImplies(B, A)\\nImplies(RAD51 homolog 1 is involved in homologous recombination repair  in humans, BRCA2 is involved in homologous recombination repair  in humans)\\n--------\\nImplies(Not(A), D)\\nImplies(Not(BRCA2 is involved in homologous recombination repair  in humans), The process is promoted by BRCA2 via RAD51 homolog 1 in humans)\\n--------\\nImplies(Not(D), B)\\nImplies(Not(The process is promoted by BRCA2 via RAD51 homolog 1 in humans), RAD51 homolog 1 is involved in homologous recombination repair  in humans)\\n--------\\nImplies(Not(B), Not(D))\\nImplies(Not(RAD51 homolog 1 is involved in homologous recombination repair  in humans), Not(The process is promoted by BRCA2 via RAD51 homolog 1 in humans))\\n--------\\nImplies(Not(A), Not(B))\\nImplies(Not(BRCA2 is involved in homologous recombination repair  in humans), Not(RAD51 homolog 1 is involved in homologous recombination repair  in humans))\\n--------\\nImplies(Not(D), A)\\nImplies(Not(The process is promoted by BRCA2 via RAD51 homolog 1 in humans), BRCA2 is involved in homologous recombination repair  in humans)\\n--------\\nImplies(C, B)\\nImplies(The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules, RAD51 homolog 1 is involved in homologous recombination repair  in humans)\\n--------\\nImplies(Not(B), Not(C))\\nImplies(Not(RAD51 homolog 1 is involved in homologous recombination repair  in humans), Not(The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules))\\n--------\\nImplies(Not(B), B)\\nImplies(Not(RAD51 homolog 1 is involved in homologous recombination repair  in humans), RAD51 homolog 1 is involved in homologous recombination repair  in humans)\\n--------\\nImplies(C, A)\\nImplies(The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules, BRCA2 is involved in homologous recombination repair  in humans)\\n--------\\nImplies(Not(B), C)\\nImplies(Not(RAD51 homolog 1 is involved in homologous recombination repair  in humans), The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules)\\n--------\\n'}",
            "9 iteration: {'syntactic validity': True, 'error code': '(* Explanation 2 provides a logical relation that the binding of BRCA2 and RAD51 catalyzes the joining of undamaged homologous molecules, and this process is promoted by BRCA2 via RAD51 in humans. *)\\n(* We can use this to infer the necessary conditions for the hypothesis. *)\\nfrom explanation_2 obtain e2 where \"Joining e2 \u2227 Undamaged y \u2227 Homologous y \u2227 Promote e2 \u2227 Agent e2 x \u2227 Patient e2 y \u2227 Via e2 z \u2227 In e2 e1\" sledgehammer', 'solving time': 103.05567598342896, 'proof tactics': [], 'code': 'theory clinical_58_9\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  BRCA2 :: \"entity \u21d2 bool\"\\n  RAD51 :: \"entity \u21d2 bool\"\\n  HRR :: \"entity \u21d2 bool\"\\n  Human :: \"entity \u21d2 bool\"\\n  Involved :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  In :: \"event \u21d2 entity \u21d2 bool\"\\n  Binding :: \"event \u21d2 bool\"\\n  Joining :: \"event \u21d2 bool\"\\n  Catalyze :: \"event \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  Undamaged :: \"entity \u21d2 bool\"\\n  Homologous :: \"entity \u21d2 bool\"\\n  Promote :: \"event \u21d2 bool\"\\n  Via :: \"event \u21d2 entity \u21d2 bool\"\\n  Molecules :: \"entity \u21d2 bool\"\\n\\n(* Explanation 1: BRCA2 and RAD51 homolog 1 are both involved in homologous recombination repair (HRR) in humans. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y z e. BRCA2 x \u2227 RAD51 y \u2227 HRR z \u2227 Human w \u2227 Involved e \u2227 Agent e x \u2227 Agent e y \u2227 In e z\"\\n\\n(* Explanation 2: The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules, and this process is promoted by BRCA2 via RAD51 homolog 1 in humans. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z w e1 e2 e3. BRCA2 x \u2227 RAD51 y \u2227 Molecules z \u2227 Human w \u2227 Binding e1 \u2227 Joining e2 \u2227 Catalyze e1 \u2227 Agent e1 x \u2227 Agent e1 y \u2227 Patient e1 z \u2227 Undamaged z \u2227 Homologous z \u2227 Promote e3 \u2227 Agent e3 x \u2227 Patient e3 z \u2227 Via e3 y \u2227 In e3 w\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"BRCA2 x \u2227 Molecules y \u2227 RAD51 z \u2227 Human e1\"\\n  (* Hypothesis: BRCA2 promotes the joining of undamaged homologous repair molecules via RAD51 homolog 1 in humans. *)\\n  shows \"\u2203x y z e1 e2. BRCA2 x \u2227 Molecules y \u2227 RAD51 z \u2227 Human e1 \u2227 Joining e2 \u2227 Undamaged y \u2227 Homologous y \u2227 Promote e2 \u2227 Agent e2 x \u2227 Patient e2 y \u2227 Via e2 z \u2227 In e2 e1\"\\nproof -\\n  (* From the premise, we have known information about BRCA2, Molecules, RAD51, and Human. *)\\n  from asm have \"BRCA2 x \u2227 Molecules y \u2227 RAD51 z \u2227 Human e1\" <ATP>\\n  (* Explanation 2 provides a logical relation that the binding of BRCA2 and RAD51 catalyzes the joining of undamaged homologous molecules, and this process is promoted by BRCA2 via RAD51 in humans. *)\\n  (* We can use this to infer the necessary conditions for the hypothesis. *)\\n  from explanation_2 obtain e2 where \"Joining e2 \u2227 Undamaged y \u2227 Homologous y \u2227 Promote e2 \u2227 Agent e2 x \u2227 Patient e2 y \u2227 Via e2 z \u2227 In e2 e1\" <ATP>\\n  (* Combine the known information and the derived conditions to satisfy the hypothesis. *)\\n  then have \"\u2203x y z e1 e2. BRCA2 x \u2227 Molecules y \u2227 RAD51 z \u2227 Human e1 \u2227 Joining e2 \u2227 Undamaged y \u2227 Homologous y \u2227 Promote e2 \u2227 Agent e2 x \u2227 Patient e2 y \u2227 Via e2 z \u2227 In e2 e1\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: BRCA2 is involved in homologous recombination repair (HRR) in humans (from Explanatory Sentence 1)\\nB: RAD51 homolog 1 is involved in homologous recombination repair (HRR) in humans (from Explanatory Sentence 1)\\nC: The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules (from Explanatory Sentence 2)\\nD: The process is promoted by BRCA2 via RAD51 homolog 1 in humans (from Explanatory Sentence 2)\\n\\nLogical Relations:\\nAnd(A, B)\\nA & B\\n--------\\nImplies(And(A, B), C)\\nImplies(A & B, The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules)\\n--------\\nImplies(C, D)\\nImplies(The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules, The process is promoted by BRCA2 via RAD51 homolog 1 in humans)\\n--------\\n\\nDerived Implications:\\nImplies(Not(B), A)\\nImplies(Not(RAD51 homolog 1 is involved in homologous recombination repair  in humans), BRCA2 is involved in homologous recombination repair  in humans)\\n--------\\nImplies(Not(C), Not(D))\\nImplies(Not(The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules), Not(The process is promoted by BRCA2 via RAD51 homolog 1 in humans))\\n--------\\nImplies(Not(A), Not(D))\\nImplies(Not(BRCA2 is involved in homologous recombination repair  in humans), Not(The process is promoted by BRCA2 via RAD51 homolog 1 in humans))\\n--------\\nImplies(D, B)\\nImplies(The process is promoted by BRCA2 via RAD51 homolog 1 in humans, RAD51 homolog 1 is involved in homologous recombination repair  in humans)\\n--------\\nImplies(Not(D), D)\\nImplies(Not(The process is promoted by BRCA2 via RAD51 homolog 1 in humans), The process is promoted by BRCA2 via RAD51 homolog 1 in humans)\\n--------\\nImplies(D, C)\\nImplies(The process is promoted by BRCA2 via RAD51 homolog 1 in humans, The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules)\\n--------\\nImplies(Not(A), Not(C))\\nImplies(Not(BRCA2 is involved in homologous recombination repair  in humans), Not(The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules))\\n--------\\nImplies(Not(C), B)\\nImplies(Not(The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules), RAD51 homolog 1 is involved in homologous recombination repair  in humans)\\n--------\\nImplies(Not(A), B)\\nImplies(Not(BRCA2 is involved in homologous recombination repair  in humans), RAD51 homolog 1 is involved in homologous recombination repair  in humans)\\n--------\\nImplies(D, A)\\nImplies(The process is promoted by BRCA2 via RAD51 homolog 1 in humans, BRCA2 is involved in homologous recombination repair  in humans)\\n--------\\nImplies(Not(C), C)\\nImplies(Not(The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules), The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules)\\n--------\\nImplies(Not(A), C)\\nImplies(Not(BRCA2 is involved in homologous recombination repair  in humans), The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules)\\n--------\\nImplies(Not(D), Not(A))\\nImplies(Not(The process is promoted by BRCA2 via RAD51 homolog 1 in humans), Not(BRCA2 is involved in homologous recombination repair  in humans))\\n--------\\nImplies(Not(C), A)\\nImplies(Not(The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules), BRCA2 is involved in homologous recombination repair  in humans)\\n--------\\nImplies(Not(A), A)\\nImplies(Not(BRCA2 is involved in homologous recombination repair  in humans), BRCA2 is involved in homologous recombination repair  in humans)\\n--------\\nImplies(Not(B), D)\\nImplies(Not(RAD51 homolog 1 is involved in homologous recombination repair  in humans), The process is promoted by BRCA2 via RAD51 homolog 1 in humans)\\n--------\\nImplies(Not(D), Not(B))\\nImplies(Not(The process is promoted by BRCA2 via RAD51 homolog 1 in humans), Not(RAD51 homolog 1 is involved in homologous recombination repair  in humans))\\n--------\\nImplies(Not(B), Not(A))\\nImplies(Not(RAD51 homolog 1 is involved in homologous recombination repair  in humans), Not(BRCA2 is involved in homologous recombination repair  in humans))\\n--------\\nImplies(B, C)\\nImplies(RAD51 homolog 1 is involved in homologous recombination repair  in humans, The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules)\\n--------\\nImplies(A, B)\\nImplies(BRCA2 is involved in homologous recombination repair  in humans, RAD51 homolog 1 is involved in homologous recombination repair  in humans)\\n--------\\nImplies(B, A)\\nImplies(RAD51 homolog 1 is involved in homologous recombination repair  in humans, BRCA2 is involved in homologous recombination repair  in humans)\\n--------\\nImplies(A, C)\\nImplies(BRCA2 is involved in homologous recombination repair  in humans, The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules)\\n--------\\nImplies(Not(C), D)\\nImplies(Not(The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules), The process is promoted by BRCA2 via RAD51 homolog 1 in humans)\\n--------\\nImplies(Not(A), D)\\nImplies(Not(BRCA2 is involved in homologous recombination repair  in humans), The process is promoted by BRCA2 via RAD51 homolog 1 in humans)\\n--------\\nImplies(Not(D), B)\\nImplies(Not(The process is promoted by BRCA2 via RAD51 homolog 1 in humans), RAD51 homolog 1 is involved in homologous recombination repair  in humans)\\n--------\\nImplies(Not(C), Not(A))\\nImplies(Not(The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules), Not(BRCA2 is involved in homologous recombination repair  in humans))\\n--------\\nImplies(Not(B), Not(D))\\nImplies(Not(RAD51 homolog 1 is involved in homologous recombination repair  in humans), Not(The process is promoted by BRCA2 via RAD51 homolog 1 in humans))\\n--------\\nImplies(Not(C), Not(B))\\nImplies(Not(The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules), Not(RAD51 homolog 1 is involved in homologous recombination repair  in humans))\\n--------\\nImplies(Not(A), Not(B))\\nImplies(Not(BRCA2 is involved in homologous recombination repair  in humans), Not(RAD51 homolog 1 is involved in homologous recombination repair  in humans))\\n--------\\nImplies(B, D)\\nImplies(RAD51 homolog 1 is involved in homologous recombination repair  in humans, The process is promoted by BRCA2 via RAD51 homolog 1 in humans)\\n--------\\nImplies(Not(D), C)\\nImplies(Not(The process is promoted by BRCA2 via RAD51 homolog 1 in humans), The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules)\\n--------\\nImplies(Not(D), A)\\nImplies(Not(The process is promoted by BRCA2 via RAD51 homolog 1 in humans), BRCA2 is involved in homologous recombination repair  in humans)\\n--------\\nImplies(C, B)\\nImplies(The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules, RAD51 homolog 1 is involved in homologous recombination repair  in humans)\\n--------\\nImplies(Not(B), Not(C))\\nImplies(Not(RAD51 homolog 1 is involved in homologous recombination repair  in humans), Not(The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules))\\n--------\\nImplies(Not(B), B)\\nImplies(Not(RAD51 homolog 1 is involved in homologous recombination repair  in humans), RAD51 homolog 1 is involved in homologous recombination repair  in humans)\\n--------\\nImplies(A, D)\\nImplies(BRCA2 is involved in homologous recombination repair  in humans, The process is promoted by BRCA2 via RAD51 homolog 1 in humans)\\n--------\\nImplies(C, A)\\nImplies(The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules, BRCA2 is involved in homologous recombination repair  in humans)\\n--------\\nImplies(Not(B), C)\\nImplies(Not(RAD51 homolog 1 is involved in homologous recombination repair  in humans), The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules)\\n--------\\n'}",
            "10 iteration: {'syntactic validity': True, 'error code': '(* Explanation 3 states that BRCA2 promotes the joining of undamaged homologous molecules via RAD51 homolog 1 by facilitating the binding and catalyzing process in humans. *)\\n(* This directly relates to the hypothesis we want to prove. *)\\n(* We can use the logical relation Implies(A, D) from the derived implications, which states that if BRCA2 is involved in homologous recombination repair in humans, then BRCA2 promotes the joining of undamaged homologous molecules via RAD51 homolog 1. *)\\n(* Since we have BRCA2 x from the premise, we can infer the hypothesis. *)\\nthen have \"\u2203e2. Joining e2 \u2227 Agent e2 y \u2227 Promote e2 \u2227 Via e2 z \u2227 In e2 e1\" sledgehammer', 'solving time': 103.11569571495056, 'proof tactics': [], 'code': 'theory clinical_58_10\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  BRCA2 :: \"entity \u21d2 bool\"\\n  RAD51 :: \"entity \u21d2 bool\"\\n  HRR :: \"entity \u21d2 bool\"\\n  Human :: \"entity \u21d2 bool\"\\n  Involved :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  In :: \"event \u21d2 entity \u21d2 bool\"\\n  Molecules :: \"entity \u21d2 bool\"\\n  Binding :: \"event \u21d2 bool\"\\n  Catalyze :: \"event \u21d2 bool\"\\n  Joining :: \"event \u21d2 bool\"\\n  Promote :: \"event \u21d2 bool\"\\n  Via :: \"event \u21d2 entity \u21d2 bool\"\\n  Facilitate :: \"event \u21d2 bool\"\\n\\n(* Explanation 1: BRCA2 and RAD51 homolog 1 are both involved in homologous recombination repair (HRR) in humans. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y z e. BRCA2 x \u2227 RAD51 y \u2227 HRR z \u2227 Human z \u2227 Involved e \u2227 Agent e x \u2227 Agent e y \u2227 In e z\"\\n\\n(* Explanation 2: The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules in humans. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z e1 e2. BRCA2 x \u2227 RAD51 y \u2227 Molecules z \u2227 Human e1 \u2227 Binding e2 \u2227 Agent e2 x \u2227 Agent e2 y \u2227 Catalyze e2 \u2227 Joining e2 \u2227 In e2 e1\"\\n\\n(* Explanation 3: BRCA2 promotes the joining of undamaged homologous molecules via RAD51 homolog 1 by facilitating the binding and catalyzing process in humans. *)\\naxiomatization where\\n  explanation_3: \"\u2203x y z w e1 e2 e3. BRCA2 x \u2227 Molecules y \u2227 RAD51 z \u2227 Human w \u2227 Joining e1 \u2227 Agent e1 y \u2227 Promote e1 \u2227 Via e1 z \u2227 Facilitate e2 \u2227 Binding e2 \u2227 Catalyze e2 \u2227 In e1 w\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"BRCA2 x \u2227 Molecules y \u2227 RAD51 z \u2227 Human e1\"\\n  (* Hypothesis: BRCA2 promotes the joining of undamaged homologous repair molecules via RAD51 homolog 1 in humans. *)\\n  shows \"\u2203x y z e1 e2. BRCA2 x \u2227 Molecules y \u2227 RAD51 z \u2227 Human e1 \u2227 Joining e2 \u2227 Agent e2 y \u2227 Promote e2 \u2227 Via e2 z \u2227 In e2 e1\"\\nproof -\\n  (* From the premise, we have known information about BRCA2, Molecules, RAD51, and Human. *)\\n  from asm have \"BRCA2 x \u2227 Molecules y \u2227 RAD51 z \u2227 Human e1\" <ATP>\\n  (* Explanation 3 states that BRCA2 promotes the joining of undamaged homologous molecules via RAD51 homolog 1 by facilitating the binding and catalyzing process in humans. *)\\n  (* This directly relates to the hypothesis we want to prove. *)\\n  (* We can use the logical relation Implies(A, D) from the derived implications, which states that if BRCA2 is involved in homologous recombination repair in humans, then BRCA2 promotes the joining of undamaged homologous molecules via RAD51 homolog 1. *)\\n  (* Since we have BRCA2 x from the premise, we can infer the hypothesis. *)\\n  then have \"\u2203e2. Joining e2 \u2227 Agent e2 y \u2227 Promote e2 \u2227 Via e2 z \u2227 In e2 e1\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: BRCA2 is involved in homologous recombination repair (HRR) in humans (from Explanatory Sentence 1)\\nB: RAD51 homolog 1 is involved in homologous recombination repair (HRR) in humans (from Explanatory Sentence 1)\\nC: The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules in humans (from Explanatory Sentence 2)\\nD: BRCA2 promotes the joining of undamaged homologous molecules via RAD51 homolog 1 by facilitating the binding and catalyzing process in humans (from Explanatory Sentence 3)\\n\\nLogical Relations:\\nAnd(A, B)\\nA & B\\n--------\\nImplies(And(A, B), C)\\nImplies(A & B, The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules in humans)\\n--------\\nImplies(A, D)\\nImplies(BRCA2 is involved in homologous recombination repair  in humans, BRCA2 promotes the joining of undamaged homologous molecules via RAD51 homolog 1 by facilitating the binding and catalyzing process in humans)\\n--------\\n\\nDerived Implications:\\nImplies(Not(B), A)\\nImplies(Not(RAD51 homolog 1 is involved in homologous recombination repair  in humans), BRCA2 is involved in homologous recombination repair  in humans)\\n--------\\nImplies(Not(C), Not(D))\\nImplies(Not(The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules in humans), Not(BRCA2 promotes the joining of undamaged homologous molecules via RAD51 homolog 1 by facilitating the binding and catalyzing process in humans))\\n--------\\nImplies(Not(A), Not(D))\\nImplies(Not(BRCA2 is involved in homologous recombination repair  in humans), Not(BRCA2 promotes the joining of undamaged homologous molecules via RAD51 homolog 1 by facilitating the binding and catalyzing process in humans))\\n--------\\nImplies(D, B)\\nImplies(BRCA2 promotes the joining of undamaged homologous molecules via RAD51 homolog 1 by facilitating the binding and catalyzing process in humans, RAD51 homolog 1 is involved in homologous recombination repair  in humans)\\n--------\\nImplies(Not(D), D)\\nImplies(Not(BRCA2 promotes the joining of undamaged homologous molecules via RAD51 homolog 1 by facilitating the binding and catalyzing process in humans), BRCA2 promotes the joining of undamaged homologous molecules via RAD51 homolog 1 by facilitating the binding and catalyzing process in humans)\\n--------\\nImplies(D, C)\\nImplies(BRCA2 promotes the joining of undamaged homologous molecules via RAD51 homolog 1 by facilitating the binding and catalyzing process in humans, The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules in humans)\\n--------\\nImplies(Not(A), Not(C))\\nImplies(Not(BRCA2 is involved in homologous recombination repair  in humans), Not(The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules in humans))\\n--------\\nImplies(Not(C), B)\\nImplies(Not(The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules in humans), RAD51 homolog 1 is involved in homologous recombination repair  in humans)\\n--------\\nImplies(Not(A), B)\\nImplies(Not(BRCA2 is involved in homologous recombination repair  in humans), RAD51 homolog 1 is involved in homologous recombination repair  in humans)\\n--------\\nImplies(D, A)\\nImplies(BRCA2 promotes the joining of undamaged homologous molecules via RAD51 homolog 1 by facilitating the binding and catalyzing process in humans, BRCA2 is involved in homologous recombination repair  in humans)\\n--------\\nImplies(Not(C), C)\\nImplies(Not(The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules in humans), The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules in humans)\\n--------\\nImplies(Not(A), C)\\nImplies(Not(BRCA2 is involved in homologous recombination repair  in humans), The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules in humans)\\n--------\\nImplies(C, D)\\nImplies(The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules in humans, BRCA2 promotes the joining of undamaged homologous molecules via RAD51 homolog 1 by facilitating the binding and catalyzing process in humans)\\n--------\\nImplies(Not(C), A)\\nImplies(Not(The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules in humans), BRCA2 is involved in homologous recombination repair  in humans)\\n--------\\nImplies(Not(A), A)\\nImplies(Not(BRCA2 is involved in homologous recombination repair  in humans), BRCA2 is involved in homologous recombination repair  in humans)\\n--------\\nImplies(Not(B), D)\\nImplies(Not(RAD51 homolog 1 is involved in homologous recombination repair  in humans), BRCA2 promotes the joining of undamaged homologous molecules via RAD51 homolog 1 by facilitating the binding and catalyzing process in humans)\\n--------\\nImplies(Not(D), Not(B))\\nImplies(Not(BRCA2 promotes the joining of undamaged homologous molecules via RAD51 homolog 1 by facilitating the binding and catalyzing process in humans), Not(RAD51 homolog 1 is involved in homologous recombination repair  in humans))\\n--------\\nImplies(Not(B), Not(A))\\nImplies(Not(RAD51 homolog 1 is involved in homologous recombination repair  in humans), Not(BRCA2 is involved in homologous recombination repair  in humans))\\n--------\\nImplies(B, C)\\nImplies(RAD51 homolog 1 is involved in homologous recombination repair  in humans, The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules in humans)\\n--------\\nImplies(A, B)\\nImplies(BRCA2 is involved in homologous recombination repair  in humans, RAD51 homolog 1 is involved in homologous recombination repair  in humans)\\n--------\\nImplies(B, A)\\nImplies(RAD51 homolog 1 is involved in homologous recombination repair  in humans, BRCA2 is involved in homologous recombination repair  in humans)\\n--------\\nImplies(A, C)\\nImplies(BRCA2 is involved in homologous recombination repair  in humans, The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules in humans)\\n--------\\nImplies(Not(C), D)\\nImplies(Not(The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules in humans), BRCA2 promotes the joining of undamaged homologous molecules via RAD51 homolog 1 by facilitating the binding and catalyzing process in humans)\\n--------\\nImplies(Not(A), D)\\nImplies(Not(BRCA2 is involved in homologous recombination repair  in humans), BRCA2 promotes the joining of undamaged homologous molecules via RAD51 homolog 1 by facilitating the binding and catalyzing process in humans)\\n--------\\nImplies(Not(D), B)\\nImplies(Not(BRCA2 promotes the joining of undamaged homologous molecules via RAD51 homolog 1 by facilitating the binding and catalyzing process in humans), RAD51 homolog 1 is involved in homologous recombination repair  in humans)\\n--------\\nImplies(Not(C), Not(A))\\nImplies(Not(The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules in humans), Not(BRCA2 is involved in homologous recombination repair  in humans))\\n--------\\nImplies(Not(B), Not(D))\\nImplies(Not(RAD51 homolog 1 is involved in homologous recombination repair  in humans), Not(BRCA2 promotes the joining of undamaged homologous molecules via RAD51 homolog 1 by facilitating the binding and catalyzing process in humans))\\n--------\\nImplies(Not(C), Not(B))\\nImplies(Not(The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules in humans), Not(RAD51 homolog 1 is involved in homologous recombination repair  in humans))\\n--------\\nImplies(Not(A), Not(B))\\nImplies(Not(BRCA2 is involved in homologous recombination repair  in humans), Not(RAD51 homolog 1 is involved in homologous recombination repair  in humans))\\n--------\\nImplies(Not(D), Not(C))\\nImplies(Not(BRCA2 promotes the joining of undamaged homologous molecules via RAD51 homolog 1 by facilitating the binding and catalyzing process in humans), Not(The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules in humans))\\n--------\\nImplies(B, D)\\nImplies(RAD51 homolog 1 is involved in homologous recombination repair  in humans, BRCA2 promotes the joining of undamaged homologous molecules via RAD51 homolog 1 by facilitating the binding and catalyzing process in humans)\\n--------\\nImplies(Not(D), C)\\nImplies(Not(BRCA2 promotes the joining of undamaged homologous molecules via RAD51 homolog 1 by facilitating the binding and catalyzing process in humans), The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules in humans)\\n--------\\nImplies(Not(D), A)\\nImplies(Not(BRCA2 promotes the joining of undamaged homologous molecules via RAD51 homolog 1 by facilitating the binding and catalyzing process in humans), BRCA2 is involved in homologous recombination repair  in humans)\\n--------\\nImplies(C, B)\\nImplies(The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules in humans, RAD51 homolog 1 is involved in homologous recombination repair  in humans)\\n--------\\nImplies(Not(B), Not(C))\\nImplies(Not(RAD51 homolog 1 is involved in homologous recombination repair  in humans), Not(The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules in humans))\\n--------\\nImplies(Not(B), B)\\nImplies(Not(RAD51 homolog 1 is involved in homologous recombination repair  in humans), RAD51 homolog 1 is involved in homologous recombination repair  in humans)\\n--------\\nImplies(C, A)\\nImplies(The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules in humans, BRCA2 is involved in homologous recombination repair  in humans)\\n--------\\nImplies(Not(B), C)\\nImplies(Not(RAD51 homolog 1 is involved in homologous recombination repair  in humans), The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules in humans)\\n--------\\n'}"
        ]
    }
}